Field
The present application relates to medical devices and, more particularly, to a medical device and method for treating the spine.
Description of the Related Art
The human spine is a flexible weight bearing column formed from a plurality of bones called vertebrae. There are thirty-three vertebrae, which can be grouped into one of five regions (cervical, thoracic, lumbar, sacral, and coccygeal). Moving down the spine, there are generally seven cervical vertebrae, twelve thoracic vertebrae, five lumbar vertebrae, five sacral vertebrae, and four coccygeal vertebrae. The vertebrae of the cervical, thoracic, and lumbar regions of the spine are typically separate throughout the life of an individual. In contrast, the vertebra of the sacral and coccygeal regions in an adult are fused to form two bones, the five sacral vertebrae which form the sacrum and the four coccygeal vertebrae which form the coccyx.
In general, each vertebra contains an anterior, solid segment or body and a posterior segment or arch. The arch is generally formed of two pedicles and two laminae, supporting seven processes—four articular, two transverse, and one spinous. There are exceptions to these general characteristics of a vertebra. For example, the first cervical vertebra (atlas vertebra) has neither a body nor spinous process. In addition, the second cervical vertebra (axis vertebra) has an odontoid process, which is a strong, prominent process, shaped like a tooth, rising perpendicularly from the upper surface of the body of the axis vertebra. Further details regarding the construction of the spine may be found in such common references as Gray's Anatomy, Crown Publishers, Inc., 1977, pp. 33-54, which is herein incorporated by reference.
The human vertebrae and associated connective elements are subjected to a variety of diseases and conditions which cause pain and disability. Among these diseases and conditions are spondylosis, spondylolisthesis, vertebral instability, spinal stenosis and degenerated, herniated, or degenerated and herniated intervertebral discs. Additionally, the vertebrae and associated connective elements are subject to injuries, including fractures and torn ligaments and surgical manipulations, including laminectomies.
The pain and disability related to the diseases and conditions often result from the displacement of all or part of a vertebra from the remainder of the vertebral column. Over the past two decades, a variety of methods have been developed to restore the displaced vertebra to their normal position and to fix them within the vertebral column. Spinal fusion is one such method. In spinal fusion, one or more of the vertebra of the spine are united together (“fused”) so that motion no longer occurs between them. Thus, spinal fusion is the process by which the damaged disc is replaced and the spacing between the vertebrae is restored, thereby eliminating the instability and removing the pressure on neurological elements that cause pain.
Spinal fusion can be accomplished by providing an intervertebral implant between adjacent vertebrae to recreate the natural intervertebral spacing between adjacent vertebrae. Once the implant is inserted into the intervertebral space, osteogenic substances, such as autogenous bone graft or bone allograft, can be strategically implanted adjacent the implant to prompt bone in-growth in the intervertebral space. The bone ingrowth promotes long-term fixation of the adjacent vertebrae. Various posterior fixation devices (e.g., fixation rods, screws etc.) can also be utilize to provide additional stabilization during the fusion process.
Notwithstanding the variety of efforts in the prior art described above, these intervertebral implants and techniques are associated with another disadvantage. In particular, these techniques typically involve an open surgical procedure, which results in higher cost, lengthy in-patient hospital stays and the pain associated with open procedures. In addition, many intervertebral implants are inserted anteriorly while posterior fixation devices are inserted posteriorly. This results in additional movement of the patient. Therefore, there remains a need in the art for an improved apparatus and method for introducing an intervertebral implant.
One embodiment comprises an intervertebral implant that includes a first body portion comprising a first member, a second member, and a first joint portion. A first shaft is provide such that the first member and the second member are pivotable around the shaft. A second body portion comprises a first member, a second member, and a second joint portion. A second shaft is provided and the first member of the second body portion and the second member of the second body portion are pivotable around the shaft. The first joint portion is removably connected to the second joint portion.
Any of the implant features described in the specification can be included in any embodiment. For example, the first and second body portions can include one or more aperture, one or more textured surfaces, and/or a bioactive coating. The one or more textured surfaces can include a ribbed surface, spikes, or other features to engage or anchor the implant into the bone and resist movement. In certain aspects, the first joint portion and the second joint portion form a ball and socket joint. In certain aspects, the implant includes one or more depressions configured for interaction with a deployment tool.
Another embodiment comprises an intervertebral implant that includes a body portion including a first member and a second member. The first body portion includes an open configuration and a closed configuration. A shaft extends through the first body portion and the first member of the first body portion and the second member are pivotable around the shaft from the closed configuration to the open configuration. The body portion includes a motion limiting portion to limit rotational movement of first member relative to the second member when the body portion is in the open configuration.
Any of the implant features described in the specification can be included in any embodiment. For example, the first member can be configured to translate along a central axis of the shaft. In certain aspects, one or more surfaces of the body portion can include a textured surface, one or more apertures, and/or a bioactive coating. The textured surface can include a ribbed surface, spikes, or other features to engage or anchor the implant into the bone and resist movement. In certain aspects, the body portion can include one or more depressions configured for interaction with a deployment tool. In certain aspects, the body portion can include a spring-loaded mechanism capable of transitioning the body portion from the closed configuration to the open configuration.
Another embodiment comprises a method of performing orthopedic surgery. The method includes engaging a first body portion with a deployment tool, delivering the first body portion into an intervertebral space; and transitioning the first body portion from a closed configuration to an open configuration.
Any of the method steps described in the specification can be included in any embodiment. For example, delivering the first body portion can include delivering the first body portion through a posterolateral approach. In certain aspects, delivering the first body portion through the posterolateral approach can include delivering the first body portion through a Kambin's triangle. In certain aspects, the method can include: engaging a second body portion with the deployment tool; delivering the second body portion into the intervertebral space; and transitioning the second body portion from a closed configuration to an open configuration. In certain aspects, the method can include connecting a first joint portion of the first body portion to a second joint portion of the second body portion.
For purposes of summarizing the disclosure, certain aspects, advantages and features of the inventions have been described herein. It is to be understood that not necessarily any or all such advantages are achieved in accordance with any particular embodiment of the inventions disclosed herein. No aspects of this disclosure are essential or indispensable.
The abovementioned and other features of the inventions disclosed herein are described below with reference to the drawings of the preferred embodiments. The illustrated embodiments are intended to illustrate, but not to limit the inventions. The drawings contain the following figures:
In accordance with certain embodiments disclosed herein, an improved apparatus for inserting an intervertebral implant is provided. For example, in one embodiment, the apparatus may be used to insert surgical instruments and/or one or more intervertebral implants through a minimally invasive procedure to reduce trauma to the patient and thereby enhance recovery and improve overall results. By minimally invasive, Applicant means a procedure performed percutaneously through an access device in contrast to a typically more invasive open surgical procedure.
Certain embodiments disclosed herein are discussed in the context of an intervertebral implant and spinal fusion because of the device and methods have applicability and usefulness in such a field. The device can be used for fusion, for example, by inserting an intervertebral implant to properly space adjacent vertebrae in situations where a disc has ruptured or otherwise been damaged. “Adjacent” vertebrae can include those vertebrae originally separated only by a disc or those that are separated by intermediate vertebra and discs. Such embodiments can therefore be used to create proper disc height and spinal curvature as required in order to restore normal anatomical locations and distances. However, it is contemplated that the teachings and embodiments disclosed herein can be beneficially implemented in a variety of other operational settings, for spinal surgery and otherwise.
Certain embodiments disclosed herein are discussed in the context of an intervertebral implant that can preserve at least some degree of motion between two adjacent vertebrae. In one arrangement, the intervertebral implant is configured to be inserted through the Kambin triangle (as described below) in a reduced cross-sectional profile. Once the implant is passed through the Kambin triangle, the implant can be converted into a second, larger cross-sectional profile in which the device can engage and maintain separation of the adjacent vertebra while still allowing least some degree of motion between two adjacent vertebrae.
As context for the methods and devices described herein,
Dilation Introducer
Although the illustrated embodiment depicts the first and second dilator tubes as separate elements, in alternative embodiments these two tubes can be coupled formed together as one unified dilator tube with a staggered distal portion. In still other embodiments, the first dilator tube and second dilator tube may be coupled together to form a single component. The tubes may be joined by, for instance, welding, adhesive, mechanical joints, or any other appropriate means.
In another alternative embodiment, the first dilator tube may be omitted. Instead, a Jamshidi® needle with a removable handle, or a similar device, may be used to initially define a path to the intervertebral disc. With the handle of the Jamshidi® needle removed, the second dilator tube may be advanced over the Jamshidi® needle, just as with the first dilator tube. In some embodiments, a K-wire or similar device can be inserted through the Jamshidi® needle and/or dilator tubes.
In some embodiments, a button 67 on the handle 66 allows for the operator to toggle between a locked and unlocked configuration. In a locked configuration, the second and third dilator tubes are unable to slide relative to one another. In an embodiment, the locked configuration permits the dilator tubes to rotate independently with respect to one another. In another embodiment, the locked configuration restrains rotational movement as well as slidable movement. The button 67 may comprise a generally rectangular shape with a cut-out large enough for the collar of the second dilator tube 45 to pass therethrough. A spring located underneath the button 67 provides upward pressure on the button. When uncompressed, the cut-out portion of the button presses firmly against the collar of the second dilator tube 45, which may be received within the handle 66 of the third dilator tube. When uncompressed, the friction of the button 67 against the collar inhibits movement of the third dilator tube 60 with respect to the second dilator tube. In some embodiments, the cut-out portion of the button may form a notch configured to fit within the ridge on the collar of the third dilator tube. Upon compressing the button 67, the cut-out portion of the button may be moved away from the collar, permitting free movement of the third dilator tube 60 relative to the second dilator tube 45.
In some embodiments, a button 37 on the handle 36 allows for the operator to toggle between a locked and unlocked configuration. In a locked configuration, third dilator tube and the access cannula are unable to slide relative to one another. In an embodiment, the locked configuration permits the dilator tubes to rotate independently with respect to one another. In another embodiment, the locked configuration restrains rotational movement as well as slidable movement. The button 37 may comprise a generally rectangular shape with a cut-out large enough for the collar of the third dilator tube 60 to pass therethrough. A spring located beneath the button 37 can provide upward pressure on the button. When uncompressed, the cut-out portion of the button can press firmly against the collar of the third dilator tube 45, which may be received within the handle of the access cannula 30. When uncompressed, the friction of the button 37 against the collar can inhibit movement of the access cannula 30 with respect to the third dilator tube 60. Upon compressing the button 37, the cut-out portion of the button can be moved away from the collar, permitting free movement of the access cannula 30 relative to the third dilator tube 60.
In certain embodiments, the first, second and third dilator tubes along with the access cannula can be provided with additional stops that engage the buttons described above. For example, in one embodiment, notches or detents can be provided that engage the button when one tube is advanced distally and reaches a specific location (e.g., end point). In this manner, forward movement of a tube or cannula can be limited once the tube or cannula may be advanced to a desired location
Method of Use
As discussed above, although the illustrated embodiment shows the first and second dilator tubes as separate elements, in alternative embodiments these two tubes may be formed together as one unified dilator tube with a staggered distal portion. In still other embodiments, the first dilator tube and second dilator tube may be coupled together to form a single component. In these alternative embodiments, the unified or coupled dilator tube may be advanced until the more distal portion abuts or penetrates the intervertebral disc.
In another alternative embodiment, the first dilator tube may be omitted. Instead, a Jamshidi® needle with a removable handle or similar device may be used. In such an embodiment, the Jamshidi® needle may be first introduced to abut or enter the intervertebral disc, after which the handle may be removed. Optionally, a K-wire may be inserted into the Jamshidi® needle after it is in position either abutting or partially penetrating the intervertebral disc. The second dilator tube may then be advanced over the Jamshidi® needle.
With reference now to
As illustrated in
As can be seen in
Referring now to
An example of a surgical tool for use through the access cannula is depicted in
When the first dilator tube 140 is received within the second dilator tube 145, the longitudinal axis 127 of the second longitudinal lumen is essentially aligned with the first longitudinal axis 144. Additionally, the second dilator tube 145 can include cutting flutes or ridges 151 on one side, located opposite the opening of the generally semi-annular cross-section of the second dilator tube 145. In other embodiments, the cutting flutes 151 may be replaced with a coarse surface (e.g., knurling, sharp edges, abrasive members, etc.) which, when rotated or slid (e.g., back and forth) against bone, will create a recess therein. As noted above, other mechanisms for removing bone can be used, and the cutting flutes are shown here by way of example only. As can be seen in
In certain embodiments, the first, second and third dilator tubes 140, 145, 160 along with the access cannula 130 can be provided with additional stops that engage the proximal grip 136 of the access cannula and the handle assembly 183 of the third dilator tube described above. For example, in one embodiment, notches or detents can be provided that engage the proximal grip 136 or handle assembly 183 when one tube is advanced distally and reaches a specific location (e.g., end point). In this manner, forward movement of a tube or cannula can be limited once the tube or cannula is advanced to a desired location
Referring to
The third dilator tube 160 has a distal tip 184 with a flattened edge 185, a proximal portion 182 with a handle assembly 183, and a longitudinal lumen 164. The second dilator tube 145 may be removably received in the longitudinal lumen 164 of the third dilator tube 160 for slidable movement within the third dilator tube 160. The threaded portion 174 of the proximal head 173 of the first dilator tube engages with the interior threaded receiving portion 190 of the handle assembly 183 of the third dilator tube 160. With the proximal head of the first dilator tube affixed to the handle assembly 183, the first and third dilator tubes 140, 160 may be locked together for length and rotation. The second and third dilator tubes may be connected together in a locked configuration with a first latching button 186 disposed on the handle assembly 183 of the third dilator tube 160 and extending through a first aperture 1105 in the handle assembly 183 of the third dilator tube 160, so that the first latching button 186 may be moveable between a radially inward locking position (arrow 1101) and a radially outward unlocking position (arrow 1102).
The distal end 196 of the first latching button may be removably received in aperture 181 of the second dilator tube 145 so as to engage and lock the second and third dilators together in the locking position. Alternatively, the latching button may be received in a circumferentially oriented groove of the second dilator tube, which may or may not extend completely around the second dilator tube. The first latching button 186 may be pulled radially outwardly to release the second dilator tube 145, to allow the third dilator tube 160 to slide with respect to the second dilator tube 145.
The access cannula 130 has a distal portion 161, a proximal portion 193, a proximal grip 136, and longitudinal lumen 164. The third dilator tube 145 may be removably received within the access cannula 130 for slidable movement within the longitudinal lumen 131 of the access cannula 130. The third dilator tube 145 and the access cannula 130 also have a locked configuration in which the access cannula 130 may be not permitted to slidably telescope over the third dilator tube 145.
The proximal portion 193 of the access cannula 130 includes a proximal grip 136 with a larger diameter portion 198 and a smaller diameter portion 199. The smaller diameter portion 199 may be sized to fit under an overhanging lip 191 of the third dilator tube, when the longitudinal axes of the third dilator tube and access cannula may be aligned. There may be a circumferentially oriented channel 1107 in the exterior of the smaller diameter portion 919 for receiving a distal end 197 of a second latching button 187. The circumferentially oriented channel 1107 does not need to extend completely around the exterior of the smaller diameter portion 199.
The third dilator tube 145 and the access cannula 130 may be connected together in a locked configuration with the second latching button 187 disposed on the overhanging lip 191 of the handle assembly 183 of the third dilator tube 145. The second latching button extends through an aperture 1106 in the overhanging lip 191 of the handle assembly 183 and may be movable between a radially inward locking position (arrow 194) and a radially outward unlocking position (arrow 195). The distal end 197 of the second latching button 187 may be removably received in the channel 107 located in the smaller diameter portion 199 of the access cannula 130, in the locking position, to lock the third dilator tube 45 and the access cannula 130 in the locked assembled configuration. The second latching button 187 may be pulled radially outward to release the access cannula 130 to slide to the unlocked configuration. Furthermore, the second and third dilator tubes 140, 145 may be removed together as a unit from the access cannula 130. In other words, the first dilator tube 140 and second dilator tube 145 can be kept locked together and can be removed from the access cannula 130 by unlocking the second latching button 187 alone. An advantage of this embodiment is that the latching buttons 186, 187 may be both removable from the surgical field with the release of the third dilator tube from the access cannula 130.
The access cannula being free of protuberances, such as the latching buttons, is less likely to catch surgical sponges and sutures, for example, on the dilation introducer.
Dilation Introducer with Neuro-Monitoring
The neuro-monitoring needle 1108 can be made from several components. The wire 1108 portion can be stainless steel coated with dielectric coating 1112 of parylene. The distal tip 1111 of the wire 1109 can be exposed so that it can transmit current. The needle cannula 1110 which covers the wire 1109 can also comprise stainless steel coated with parylene. In some embodiments, this needle cannula could also be described as an exchange tube where once the wire is removed a K-wire could be placed down it and into the disc space. The wire 1109 can be attached to a handle at the proximal end ultimately protrude from the handle, serving as the electrode to attach a neuromonitoring system. In some embodiments, the proximal diameter can be parylene coated, while the rest of the wire 1109 can be uncoated to transmit the current.
The wire 1109 may comprise a conductive material, such as silver, copper, gold, aluminum, platinum, stainless steel, etc. A constant current may be applied to the wire 1109. The needle cannula 1110 may be insulated by dielectric coating 1112. Although the coating shown here is dielectric, any sufficiently insulative coating may be used. Alternatively, an insulative sleeve may encase the wire. This arrangement protects the conductive wire 1109 at all points except the most distal tip 1111. As the exposed tip of the wire 1109 is advanced through the tissue, it continues to be supplied with current. When the tip 1111 approaches a nerve, the nerve may be stimulated. The degree of stimulation to the nerve is related to the distance between the distal tip 1111 and the nerve. Stimulation of the nerve may be measured by, e.g., visually observing the patient's leg for movement, or by measuring muscle activity through electromyography (EMG) or various other known techniques.
Utilizing this configuration may provide the operator with added guidance as to the positioning of the first dilator tube to the surgical access point and through Kambin's triangle. With each movement, the operator may be alerted when the tip of the first dilator tube approaches or comes into contact with a nerve. The operator may use this technique alone or in conjunction with other positioning assistance techniques such as fluoroscopy and tactile feedback. The amount of current applied to the wire 1109 may be varied depending on the preferred sensitivity. Naturally, the greater the current supplied, the greater nerve stimulation will result at a given distance from the nerve. In various embodiments the current applied to the conductive wire 1109 may not be constant, but rather periodic or irregular. Alternatively, pulses of current may be provided only on demand from the operator.
Although not shown here, a similar configuration may be applied to the second and third dilator tubes, and to the access cannula. Each may include a conductive wire embedded within the tube, or it may be separately attached. In either configuration, a distal tip of conductive wire may be exposed and the wire may be provided with current. As the dilator tube or access cannula is advanced through the tissue and towards the access site, nerve stimulation may be monitored as described above. The current supplied to each of the first, second, and third dilator tubes and to the access cannula may be controlled independently, so that when nerve stimulation is observed, the operator may supply current separately to each wire to determine which wire or wires are nearest to the nerve. Alternatively, current may be supplied only to one wire at any given point in the procedure. For example, the current may be supplied to the wire associated with the dilator tube or access cannula that is being moved at that point in the operation.
In some embodiments, the second and third dilator tubes can comprise aluminum that has been anodized and then coated with parylene. Certain areas of the second and third dilator tubes can be masked from the anodization and parylene coating so that they can transmit the current. For example, the distal tips of the second and third dilator tubes can be exposed so as to conduct current therethrough. The exposed portions can be passivated to resist rusting, pitting, or corrosion. The exposed portions can be made by using a stainless steel pin pressed into the second and third dilator tubes. The pin can aid in locating the second and third dilator tubes on x-ray or fluoroscopy, and additionally can facilitate the transmission of current through the second and third dilator tubes to the area of contact. Electrode attachments for the second and third dilator tubes can be coated with parylene on the proximal larger diameter to prevent current from flowing into the user. The rest of the electrode can be uncoated, but passivated to resist rusting, pitting, or corrosion. The electrodes can attach such that the current is transmitted to the internal area of the second and third dilator tubes so that it can be transmitted distally through the exposed areas on the tips of the tubes. These tubes are attached to Radel handles, which being a polymer are also insulators. The third dilator tube can be made from stainless steel, coated with nylon or other polymer, such as Teflon, followed by a parylene coating. In embodiments in which the dilator tube comprises stainless steel, no additional x-ray marker is required.
Although the method as described above utilizes an embodiment of the dilation introducer as shown in
Alternatively, the dilation introducer equipped with neuro-monitoring, as shown in
Implant
With respect to the implant 80 described above, the implant 80 can comprise any of a variety of types of interbody devices configured to be placed between vertebral bodies. The implant 80 can be formed from a metal (e.g., titanium) or a non-metal material such as plastics, PEEK™, polymers, and rubbers. Further, the implant components can be made of combinations of non-metal materials (e.g., PEEK™, polymers) and metals. The implant 80 can be configured with a fixed or substantially fixed height, length, and width as shown, for example, in the embodiment of
With reference to
With reference to
The first body portion 502 can include one or more textured surfaces. The textured surfaces can include microscopic roughness or more easily visible protrusions. For example, one or more surfaces of the first body portion can include a ribbed surface. As shown in
The first body portion 502 can include one or more apertures to facilitate osseointegration within the intervertebral space. As shown in
The first body portion 502 can be coated with one or more bioactive substances, such as antibiotics, chemotherapeutic substances, angiogenic growth factors, substances for accelerating the healing of the wound, growth hormones, anti-thrombogenic agents, bone growth accelerators or agents, and the like.
The first body portion 502 can include an open configuration, shown in
The first body portion 502 can include one or more motion limiting portions 518, 550. Motion limiting portions 518, 550 can limit the rotational movement of the first member 504 relative to the second member 508. The motion limiting portions 518, 550 can take on different configurations. For example, as shown in
The first member 504 can translate along a central axis of the first shaft. As shown in
The first body portion 502 can transition from a closed configuration to an open configuration via a user-actuated mechanism. As another example, the first body portion 502 can be spring-loaded. In the spring-loaded example, a tubular member, such as access cannula 30, can restrain the first body portion 502 to a closed configuration, but when the first body portion 502 is delivered from the tubular member, the first body portion 502 can transition to the open configuration. A deployment tool having forceps can also restrain the first body portion 502 to the closed configuration. Releasing the first body portion from the deployment tool can transition the first body portion 502 from the closed configuration to the open configuration.
The first body portion 502 can also include one or more depressions 542, 548 to facilitate interaction with a deployment tool.
The first body portion 502 can include a metal (e.g., titanium) or a non-metal material such as plastics, PEEK™, polymers, and rubbers. Further, the implant components can be made of combinations of non-metal materials (e.g., PEEK™, polymers) and metals.
The first body portion 502 can be configured with a height, length, and width suitable for delivery through the access cannula and positioning between vertebral bodies (e.g., within the disc space within the annulus). The first member 504 can have a uniform width, or the first member 504 can include a tapered width. Further, the first member 504 can include a uniform thickness, or the first member 504 can include a tapered thickness. The second member 508 can have dimensions identical to or substantially similar to the first member 504.
As shown in
The two-piece implant 500 facilitates delivery of the implant through a smaller access site. After the implant is assembled in the intervertebral space, the two-piece implant can fill a larger space between two vertebrae than would be possible with a single component system using a similarly sized access site or access cannula.
The first body portion 502 can include a first joint portion 546, and the second body portion 520 can include a second joint portion 564. The first joint portion 546 can removably connect to the second joint portion 564. In certain aspects, the first joint portion 546 and the second joint portion 564 can form a ball and socket joint. The ball and socket joint permits motion along multiple axes. The first joint portion 546 and the second joint portion 564 can also take on any other joint configuration, including, but not limited to, a hinge joint, pivot joint, or saddle joint depending on the desirable amount of movement. In some instances, it may be desirable to limit the number of axes along which the first member 504 is capable of moving relative to the second member 508.
As shown in
Method of Delivering an Implant
The first body and second portions 502, 520 of the implant 500 can be delivered through the Kambin triangle utilizing the techniques and devices described above with reference to
As shown in
Once the first body portion 502 is in the intervertebral space, the implant can transition from the closed configuration to the open configuration. Deployment tool 600 can include an actuation mechanism configured to transition the first body portion 502 from the closed configuration to the open configuration. In another arrangement, the first body portion 502 can be spring-loaded to automatically transition to the open configuration when released from the deployment tool 600 or the cannula 30.
A filler can be injected into the intervertebral space. The filler can include any type of bone graft substance, bone cement, a carrier medium carrying bone morphogenetic proteins, or any other bone void fillers.
The deployment tool 600 can engage the second body portion 520 and deliver the second body portion 520 into the intervertebral space. Similar to the first body portion 502, the second body portion 520 can transition from the closed configuration to the open configuration using a user-actuated mechanism or a spring-loaded mechanism.
The deployment tool 600 can position the second body portion 520 relative to the first body portion 502. For example, the deployment tool 600 can connect the first joint portion 546 to the second joint portion 564, such that the second body portion 520 is capable of controlled movement relative to the first body portion 502. In some designs, the first joint portion 546 and the second joint portion 564 form a ball and socket joint.
Deployment Tool
Referring now to
According to an embodiment, the handle section 402 can comprise a fixed portion 410, and one or more rotatable portions, such as the rotatable deployment portion 412 and the rotatable tethering portion 414. In such an embodiment, the tethering portion 414 can be used to attach the implant to the tool 400 prior to insertion and deployment. The deployment portion 412 can be used to actuate the implant and rotate the actuator shaft thereof for expanding the implant. Then, after the implant is expanded and properly placed, the tethering portion 414 can again be used to untether or decouple the implant from the tool 400.
Further, the distal engagement section 404 can comprise a fixed portion 420, an anti-torque component 422, a tethering rod (element 424 shown in
For example, as illustrated in
As shown in
In some embodiments, the tool 400 can be prepared for a single-use and can be packaged with an implant preloaded onto the tool 400. This arrangement can facilitate the use of the implant and also provide a sterile implant and tool for an operation. Thus, the tool 400 can be disposable after use in deploying the implant.
Referring again to
In an embodiment, the slider element 452 and an internal cavity 456 of the tool can be configured such that the slider element 452 is provided only translational movement in the longitudinal direction of the tool 400. Accordingly, as the deployment portion 412 is rotated, the thread component 454 is also rotated. In such an embodiment, as the thread component 454 rotates and is in engagement with the slider component 452, the slider element 452 can be incrementally moved from an initial position within the cavity 456 in response to the rotation of the deployment portion 412. An indicator 458 can thus be longitudinally moved and viewed to allow the gauge 440 to visually indicate the expansion and/or height of the implant 200. In such an embodiment, the gauge 440 can comprises a transparent window through which the indicator 458 on the slider element 452 can be seen. In the illustrated embodiment, the indicator 458 can be a marking on an exterior surface of the slider element 452.
In embodiments where the tool 400 can be reused, the reset button 450 can be utilized to zero out the gauge 440 to a pre-expansion setting. In such an embodiment, the slider element 452 can be spring-loaded, as shown with the spring 460 in
Additional details and embodiments of an expandable implant can be found in U.S. Patent Application No 2008/0140207, filed Dec. 7, 2007 as U.S. patent application Ser. No. 11/952,900, the entirety of which is hereby incorporated by reference herein.
Bone Rasp
Another example of a surgical tool for use through the access cannula is a bone rasp. A rasp tool can be configured to be inserted through the access cannula 30 into the intervertebral disc space. The rasping tool can then be used to abrade or file the inferior surface of the superior vertebrae and/or the superior surface of the inferior vertebrae. The rasping tool can include an elongated body and a scraping component. A handle may be proximally attached to the elongated body.
The entire assembly can be dimensioned such that the rasping tool can slide longitudinally within the access cannula 30. In use, the rasp tool may be inserted through the access cannula until it reaches the intervertebral disc space. Using the handle, a physician may slide the elongate body and scraping component backward and forward relative to the access cannula 30. In certain embodiments, the elongate body may freely rotate within the access cannula 30, in order to permit the physician to rasp a surface at any desired angle. In other embodiments, the orientation of the elongate body may be fixed, such that rasping is only permitted along a predetermined angle relative to the access cannula 30.
In certain embodiments, the rasping tool may be expandable. For example, a rasp tool can be configured to define an unexpanded configuration. When the tool is initially inserted into the working sleeve, the tool can be positioned in the unexpanded configuration. After the tool is advanced into the intervertebral disc, the tool can be expanded to the expanded configuration.
The tool can include an elongated body and one or more scraping components. The scraping components can each include an outer surface that is configured to scrape or create friction against the disc. For example, the outer surfaces can be generally arcuate and provide an abrasive force when in contact with the interior portion of the disc. In particular, it is contemplated that once the tool is expanded, the scraping components can rasp or scrape against the vertebral end plates of the disc from within an interior cavity formed in the disc. In this manner, the tool can prepare the surfaces of the interior of the disc by removing any additional gelatinous nucleus material, as well as smoothing out the general contours of the interior surfaces of the disc. The rasping may thereby prepare the vertebral endplates for fit with the implant as well as to promote bony fusion between the vertebrae and the implant. Due to the preparation of the interior surfaces of the disc, the placement and deployment of the implant will tend to be more effective.
It is contemplated that the tool can comprise an expansion mechanism that allows the scraping components to move from the unexpanded to the expanded configuration. For example, the tool can be configured such that the scraping components expand from an outer dimension or height of approximately 9 mm to approximately 13 mm. In this regard, the expansion mechanism can be configured similarly to the expansion mechanisms of the implants disclosed herein, the disclosure for which is incorporated here and will not be repeated.
Further, it is contemplated that the scraping components can comprise one or more surface structures, such as spikes, blades, apertures, etc. that allow the scraping components to not only provide an abrasive force, but that also allowed the scraping components to remove material from the disc. In this regard, as in any of the implementations of the method, a cleaning tool can be used to remove loosened, scraped, or dislodged disc material. Accordingly, in various embodiments of the methods disclosed herein, and embodiment of the tool can be used to prepare the implant site (the interior cavity of the disc) to optimize the engagement of the implant with the surfaces of the interior of the disc (the vertebral end plates).
After the implant site has been prepared, the implant can be advanced through the access cannula and into the disc cavity. Once positioned, the implant can be expanded to its expanded configuration. For example, the implant can be expanded from approximately 9 mm to approximately 12.5 mm. Additionally, other materials or implants can then be installed prior to the removal of the access cannula and closure of the implant site.
The specific dimensions of any of the embodiment disclosed herein can be readily varied depending upon the intended application, as will be apparent to those of skill in the art in view of the disclosure herein. Moreover, although the present inventions have been described in terms of certain preferred embodiments, other embodiments of the inventions including variations in the number of parts, dimensions, configuration and materials will be apparent to those of skill in the art in view of the disclosure herein. In addition, all features discussed in connection with any one embodiment herein can be readily adapted for use in other embodiments herein to form various combinations and sub-combinations. The use of different terms or reference numerals for similar features in different embodiments does not imply differences other than those which may be expressly set forth. Accordingly, the present inventions are intended to be described solely by reference to the appended claims, and not limited to the preferred embodiments disclosed herein.
Three-Part Implant
As shown in
The upper, lower, and central body portions 602, 604, 606 can include a metal (e.g., titanium) or a non-metal material such as rubbers, plastics, Teflon®, PEEK, or other polymers. Further, the implant components can be constructed from combinations of non-metal materials and metals. For example, the upper and lower body portions 602, 604 be constructed from titanium, while the central body portion 606 can be constructed from PEEK or Teflon®. The central body portion 606 can act as a shock absorber for the implant.
The upper and lower body portions 602, 604 can include one or more of the features of the first member and second members of the first and second body portions 502, 520 of implant 500. For example, the upper body portion 602 can include a first surface 608, a second surface 610, and side surfaces 612, 614. The first and second surfaces 608, 610 can be generally curved or generally flat. As shown in
Similarly, the lower body portion 604 can include a first surface 618, a second surface 620, and side surfaces 622, 624. The first and second surfaces 618, 620 can be generally curved or generally flat. As shown in
The upper and lower body portions 602, 604 can be configured such that their respective second surfaces 610, 620 face each other, while the first surfaces 608, 618 face outward. In some arrangements, the upper and lower body portions 602, 604 can be directly or indirectly connected together, while still permitting movement between the reduced profile configuration and the increased profile configuration. For example, the implant 600 can include one or more linkages connecting the upper and lower body portions 602, 604. The linkages can connect the side surfaces of the upper and lower body portions 602, 604, connect the second surfaces 610, 620 of the upper and lower body portions 602, 604, and/or connect the ends of the upper and lower body portions 602, 604.
In some instances, the upper and lower body portions 602, 604 can be spring-loaded. In the spring-loaded example, a tubular member, such as access cannula 30, can restrain the upper and lower body portions 602, 604 to the reduced profile configuration, but when the upper and lower body portions 602, 604 are delivered from the tubular member, the upper and lower body portions 602, 604 can transition to the increased profile configuration. A deployment tool having forceps can also restrain the upper and lower body portions 602, 604 to the closed configuration. Releasing the first body portion from the deployment tool can transition the upper and lower body portions 602, 604 from the reduced profile configuration to the increased profile configuration. The upper and lower body portions 602, 604 can include one or more depressions, similar to depressions 542, 562 of implant 500 to facilitate interaction with a deployment tool.
As shown in
The upper and/or lower body portions 602, 604 can include motion limiting portions 616, 626 (e.g., notch, cutout, indentation, groove, or likewise). For example, the motion limiting portion 616 can be positioned along the second surface 610 of the upper body portion 602 and configured to interact with a corresponding motion limiting feature 638 on a first surface 630 of the central body portion 606. The motion limiting portion 616 can be centered along a length of the upper body portion 602.
The motion limiting portion 626 can be positioned along the second surface 620 of the lower body portion 604 and configured to interact with a corresponding motion limiting feature 640 on a second surface 632 of the central body portion 606. The motion limiting portion 626 can be centered along a length of the lower body portion 604.
The motion limiting features 638, 640 (e.g., notch, cutout, indentation, groove, or likewise) can be centered along a length of the central body portion 606. The section of the central body portion 606 having the motion limiting features 638, 640 can have a thickness that is less than a thickness closer to the end portions of the central body portion 606.
The motion limiting portions 616, 626 can limit rotational movement of the upper and/or lower body portions 602, 604 relative to the central body portion 606. In some instances, the motion limiting portions 616, 626 can permit limited clockwise and/or counter-clockwise rotation along a horizontal and/or vertical plane.
In some arrangements, the upper and/or lower body portions 602, 604 can include socket portions. The socket portions can take on different configurations. For example, as shown in
The socket portions can be generally centered along a length of the upper and lower body portions 602, 604, for example, within the motion limiting portions 616, 626. The ball portion 642 can be generally centered along a length of the center body portion 606, for example, the ball portion can include a hemispherical portion disposed within each of the motion limiting features 638, 640. The socket portions can be configured to interact with ball portion 642 of the central body portion 606 to form a ball and socket joint. The ball and socket joint permits motion along multiple axes.
In some arrangements, the upper and lower body portions 602, 604 can include ball portions disposed along the second surfaces 610, 620 of the upper and lower body portions 602, 604, while the central body portion 606 can include socket portions configured to interact with the ball portions.
Although
One or more surfaces of the upper, lower, and/or central body portions 602, 604, 606 can include surface modifications to facilitate tissue growth and/or help the implant engage the adjacent vertebrae. The surface modifications can include, but are not limited to, textured surfaces, ridges, grooves, apertures, and/or bioactive coatings. As shown in
The upper, lower, and/or central body portions 602, 604, 606 can include one or more apertures to facilitate osseointegration within the intervertebral space. For example, the side surfaces 612, 614, 622, 624, 632, 634 can include one or more apertures 628. The apertures 628 can facilitate circulation and bone growth throughout the intervertebral space and through the implant, thereby integrating the implant with the surrounding materials.
The upper, lower, and/or central body portions 602, 604, 606 can be coated with one or more bioactive substances, such as antibiotics, chemotherapeutic substances, angiogenic growth factors, substances for accelerating the healing of the wound, growth hormones, anti-thrombogenic agents, bone growth accelerators or agents, and the like.
As discussed above, the upper and lower body portions 602, 604 can be configured to transition to the increased profile configuration when the central body portion 606 is inserted between the upper and lower body portions 602, 604. After the upper and lower body portions 602, 604 are delivered through the Kambin triangle utilizing the techniques and devices described above, a deployment tool can engage the central body portion 606 and deliver the central body portion 606 through the cannula and into the intervertebral space. As shown in
In some instances, the central body portion 606 can be inserted between the upper and lower body portions 602, 604 by moving the central body portion 606 along an axis generally perpendicular to the longitudinal axes of the upper and lower body portions 602, 604. The central body portion 606 can be moved through an opening formed by motion limiting portions 616, 626 until the socket portions of the upper and lower body portions 602, 604 interact with the ball portion 642 of the central body portion 606.
In other instances, the central body portion 606 can be inserted between the upper and lower body portions 602, 604 by moving the central body portion 606 along an axis that is generally parallel with the longitudinal axes of the upper and lower body portions 602, 604. The central body portion 606 can inserted into a space between end portions of the upper and lower body portions 602, 604 and moved inward until the socket portions of the upper and lower body portions 602, 604 interact with the ball portion 642 of the central body portion 606. As the central body portion 606 is moved inward, the longitudinal axis of the central body portion 606 can be generally perpendicular to the longitudinal axes of the upper and lower body portions 602, 604. In certain variants, as the central body portion 606 is moved inward, the longitudinal axis of the central body portion 606 can be generally parallel to the longitudinal axes of the upper and lower body portions 602, 604. Once the ball portion 642 of the central body portion 606 interacts with the joint portions of the upper and lower body portions, the central body portion 606 can be rotated until the central body portion 606 is generally perpendicular to the upper and lower body portions 602, 604, or any other desired angle.
The terms “approximately,” “about,” and “substantially” as used herein represent an amount close to the stated amount that still performs a desired function or achieves a desired result. For example, the terms “approximately”, “about”, and “substantially” may refer to an amount that is within less than 10% of, within less than 5% of, within less than 1% of, within less than 0.1% of, and within less than 0.01% of the stated amount.
1. An intervertebral implant comprising:
2. The implant of Embodiment 1, wherein the first and second body portions include one or more apertures.
3. The implant of Embodiment 1, wherein the first and second body portions include one or more textured surfaces.
4. The implant of Embodiment 3, wherein the one or more textured surfaces includes a ribbed surface.
5. The implant of Embodiment 1, wherein the first and second body portions include a bioactive coating.
6. The implant of Embodiment 1, wherein the first joint portion and the second joint portion form a ball and socket joint.
7. The implant of Embodiment 1, wherein the first and second body portions include one or more depressions configured for interaction with a deployment tool.
8. An intervertebral implant comprising:
9. The implant of Embodiment 8, wherein the first member is configured to translate along a central axis of the shaft.
10. The implant of Embodiment 8, wherein one or more surfaces of the body portion include a textured surface.
11. The implant of Embodiment 10, wherein the textured surface is a ribbed surface.
12. The implant of Embodiment 8, further comprising one or more apertures.
13. The implant of Embodiment 8, further comprising a bioactive coating.
14. The implant of Embodiment 8, wherein the body portion includes one or more depressions configured for interaction with a deployment tool.
15. The implant of Embodiment 8, wherein the body portion includes a spring-loaded mechanism capable of transitioning the body portion from the closed configuration to the open configuration.
16. A method of performing orthopedic surgery comprising:
17. The method of Embodiment 16, wherein delivering the first body portion further comprises delivering the first body portion through a posterolateral approach.
18. The method of Embodiment 17, wherein delivering the first body portion through the posterolateral approach further comprises delivering the first body portion through a Kambin's triangle.
19. The method of Embodiment 16, further comprising:
20. The method of Embodiment 19, further comprising connecting a first joint portion of the first body portion to a second joint portion of the second body portion.
21. The steps, features, elements, acts, compositions, modules, components, examples, arrangements, and structures described or depicted herein, individually or in any combination or sub-combination thereof.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2013/057144 | 8/28/2013 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2014/036178 | 3/6/2014 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
1802560 | Kerwin | Apr 1923 | A |
2077804 | Morrison | Apr 1937 | A |
2121193 | Hanicke | Jun 1938 | A |
2243717 | Moreira | May 1941 | A |
2388056 | Hendricks | Jul 1943 | A |
2381050 | Hardinge | Aug 1945 | A |
2485531 | Dzus et al. | Oct 1949 | A |
2489870 | Dzus | Nov 1949 | A |
2570465 | Lundholm | Oct 1951 | A |
2677369 | Knowles | May 1954 | A |
3115804 | Johnson | Dec 1963 | A |
3312139 | Di Cristina | Apr 1967 | A |
3486505 | Morrison | Dec 1969 | A |
3489143 | Holloran | Jan 1970 | A |
3698391 | Mahony | Oct 1972 | A |
3760802 | Fischer et al. | Sep 1973 | A |
3805775 | Fischer et al. | Apr 1974 | A |
3811449 | Gravlee et al. | May 1974 | A |
3842825 | Wagner | Oct 1974 | A |
3848601 | Ma et al. | Nov 1974 | A |
3986504 | Avila | Oct 1976 | A |
4013071 | Rosenberg | Mar 1977 | A |
4052988 | Doddi et al. | Oct 1977 | A |
4091806 | Aginsky | May 1978 | A |
4175555 | Herbert | Nov 1979 | A |
4236512 | Aginsky | Dec 1980 | A |
4262665 | Roalstad et al. | Apr 1981 | A |
4275717 | Bolesky | Jun 1981 | A |
4312353 | Shahbabian | Jan 1982 | A |
4341206 | Perrett et al. | Jul 1982 | A |
4350151 | Scott | Sep 1982 | A |
4369790 | McCarthy | Jan 1983 | A |
4401112 | Rezaian | Aug 1983 | A |
4401433 | Luther | Aug 1983 | A |
4409974 | Freedland | Oct 1983 | A |
4449532 | Storz | May 1984 | A |
4451256 | Weikl et al. | May 1984 | A |
4456005 | Lichty | Jun 1984 | A |
4463753 | Gustilo | Aug 1984 | A |
4488543 | Tornier | Dec 1984 | A |
4494535 | Haig | Jan 1985 | A |
4532660 | Field | Aug 1985 | A |
4537185 | Stednitz | Aug 1985 | A |
4545374 | Jacobson | Oct 1985 | A |
4573448 | Kambin | Mar 1986 | A |
4601710 | Moll | Jul 1986 | A |
2173655 | Himoud | Oct 1986 | A |
4625725 | Davison et al. | Dec 1986 | A |
4629450 | Suzuki et al. | Dec 1986 | A |
4632101 | Freedland | Dec 1986 | A |
4641640 | Griggs | Feb 1987 | A |
4640271 | Lower | Mar 1987 | A |
4653489 | Tronzo | Mar 1987 | A |
4667663 | Miyata | May 1987 | A |
4686984 | Bonnet | Aug 1987 | A |
4688561 | Reese | Aug 1987 | A |
4721103 | Freedland | Jan 1988 | A |
4723544 | Moore et al. | Feb 1988 | A |
4743257 | Tormala et al. | May 1988 | A |
4760843 | Fischer et al. | Aug 1988 | A |
4790304 | Rosenberg | Dec 1988 | A |
4790817 | Luther | Dec 1988 | A |
4796612 | Reese | Jan 1989 | A |
4802479 | Haber et al. | Feb 1989 | A |
4815909 | Simons | Mar 1989 | A |
4827917 | Brumfield | May 1989 | A |
4858601 | Glisson | Aug 1989 | A |
4862891 | Smith | Sep 1989 | A |
4863476 | Shepperd | Sep 1989 | A |
4873976 | Schreiber | Oct 1989 | A |
4898186 | Ikada et al. | Feb 1990 | A |
4903692 | Reese | Feb 1990 | A |
4917554 | Bronn | Apr 1990 | A |
4940467 | Tronzo | Jul 1990 | A |
4959064 | Engelhardt | Sep 1990 | A |
4963144 | Huene | Oct 1990 | A |
4966587 | Baumgart | Oct 1990 | A |
4968317 | Tormala et al. | Nov 1990 | A |
4978334 | Toye et al. | Dec 1990 | A |
4978349 | Frigg | Dec 1990 | A |
4981482 | Ichikawa | Jan 1991 | A |
4988351 | Paulos et al. | Jan 1991 | A |
4994027 | Farrel | Feb 1991 | A |
5002557 | Hasson | Mar 1991 | A |
5011484 | Breard | Apr 1991 | A |
5013315 | Barrows | May 1991 | A |
5013316 | Goble et al. | May 1991 | A |
5059193 | Kuslich | Oct 1991 | A |
5062849 | Schelhas | Nov 1991 | A |
5080662 | Paul | Jan 1992 | A |
5084043 | Hertzmann et al. | Jan 1992 | A |
5092891 | Kummer et al. | Mar 1992 | A |
5098241 | Aldridge et al. | Mar 1992 | A |
5098433 | Freedland | Mar 1992 | A |
5098435 | Stednitz et al. | Mar 1992 | A |
5114407 | Burbank | May 1992 | A |
5116336 | Frigg | May 1992 | A |
5120171 | Lasner | Jun 1992 | A |
5122133 | Evans | Jun 1992 | A |
5122141 | Simpson et al. | Jun 1992 | A |
5139486 | Moss | Aug 1992 | A |
5158543 | Lazarus | Oct 1992 | A |
5167663 | Brumfield | Dec 1992 | A |
5167664 | Hodorek | Dec 1992 | A |
5169400 | Muhling et al. | Dec 1992 | A |
5171278 | Pisharodi | Dec 1992 | A |
5171279 | Mathews | Dec 1992 | A |
5171280 | Baumgartner | Dec 1992 | A |
5176651 | Allgood et al. | Jan 1993 | A |
5176697 | Hasson et al. | Jan 1993 | A |
5178501 | Carstairs | Jan 1993 | A |
5183464 | Dubrul et al. | Feb 1993 | A |
5188118 | Terwilliger | Feb 1993 | A |
5195506 | Hulfish | Mar 1993 | A |
5201742 | Hasson | Apr 1993 | A |
5217462 | Asnis et al. | Jun 1993 | A |
5217486 | Rice et al. | Jun 1993 | A |
5224952 | Deniega et al. | Jul 1993 | A |
5234431 | Keller | Aug 1993 | A |
5241972 | Bonati | Sep 1993 | A |
5242410 | Melker | Sep 1993 | A |
5242427 | Bilweis | Sep 1993 | A |
5242447 | Borzone | Sep 1993 | A |
5246441 | Ross et al. | Sep 1993 | A |
5250049 | Michael | Oct 1993 | A |
5269797 | Bonati et al. | Dec 1993 | A |
5280782 | Wilk | Jan 1994 | A |
5286001 | Rafeld | Feb 1994 | A |
5290243 | Chodorow et al. | Mar 1994 | A |
5300074 | Frigg | Apr 1994 | A |
5304142 | Liebl et al. | Apr 1994 | A |
5308327 | Heaven et al. | May 1994 | A |
5308352 | Koutrouvelis | May 1994 | A |
5312410 | Miller et al. | May 1994 | A |
5312417 | Wilk | May 1994 | A |
5324261 | Amundson et al. | Jun 1994 | A |
5334184 | Bimman | Aug 1994 | A |
5334204 | Clewett et al. | Aug 1994 | A |
5342382 | Brinkerhoff et al. | Aug 1994 | A |
5342365 | Waldman | Sep 1994 | A |
5344252 | Kakimoto | Sep 1994 | A |
5364398 | Chapman et al. | Nov 1994 | A |
5370646 | Reese et al. | Dec 1994 | A |
5370647 | Graber et al. | Dec 1994 | A |
5370661 | Branch | Dec 1994 | A |
5382248 | Jacobson et al. | Jan 1995 | A |
5387213 | Breard et al. | Feb 1995 | A |
5387215 | Fisher | Feb 1995 | A |
5390683 | Pisharodi | Feb 1995 | A |
5395317 | Kambin | Mar 1995 | A |
5395371 | Miller et al. | Mar 1995 | A |
5407430 | Peters | Apr 1995 | A |
5415661 | Holmes | May 1995 | A |
5424773 | Saito | Jun 1995 | A |
5449359 | Groiso | Sep 1995 | A |
5449361 | Preissman | Sep 1995 | A |
5452748 | Simmons et al. | Sep 1995 | A |
5454790 | Dubrul et al. | Oct 1995 | A |
5464427 | Curtis et al. | Nov 1995 | A |
5470333 | Ray | Nov 1995 | A |
5472426 | Bonati et al. | Dec 1995 | A |
5474539 | Costa et al. | Dec 1995 | A |
5486190 | Green | Jan 1996 | A |
5496318 | Howland et al. | Mar 1996 | A |
5498265 | Asnis et al. | Mar 1996 | A |
5501695 | Anspach, Jr. et al. | Mar 1996 | A |
5505710 | Dorsey, III | Apr 1996 | A |
5512037 | Russell et al. | Apr 1996 | A |
5514180 | Heggeness et al. | May 1996 | A |
5520690 | Errico et al. | May 1996 | A |
5520896 | De Graaf et al. | May 1996 | A |
5527312 | Ray | Jun 1996 | A |
5536127 | Pennig | Jul 1996 | A |
5540688 | Navas | Jul 1996 | A |
5540693 | Fisher | Jul 1996 | A |
5545164 | Howland | Aug 1996 | A |
5549610 | Russell et al. | Aug 1996 | A |
5554191 | Lahille et al. | Sep 1996 | A |
5558674 | Heggeness et al. | Sep 1996 | A |
D374287 | Goble et al. | Oct 1996 | S |
5564926 | Branemark | Oct 1996 | A |
5569248 | Mathews | Oct 1996 | A |
5569251 | Baker et al. | Oct 1996 | A |
5569290 | McAfee | Oct 1996 | A |
5569548 | Koike et al. | Oct 1996 | A |
5591168 | Judet et al. | Jan 1997 | A |
5609634 | Voydeville | Mar 1997 | A |
5613950 | Yoon | Mar 1997 | A |
5618142 | Sonden et al. | Apr 1997 | A |
5618314 | Harwin et al. | Apr 1997 | A |
5624447 | Myers | Apr 1997 | A |
5626613 | Schmieding | May 1997 | A |
5628751 | Sander et al. | May 1997 | A |
5628752 | Asnis et al. | May 1997 | A |
5639276 | Weinstock et al. | Jun 1997 | A |
5643320 | Lower et al. | Jul 1997 | A |
5645589 | Li | Jul 1997 | A |
5645599 | Samani | Jul 1997 | A |
5647857 | Anderson et al. | Jul 1997 | A |
5649931 | Bryant et al. | Jul 1997 | A |
5653763 | Errico et al. | Aug 1997 | A |
5658335 | Allen | Aug 1997 | A |
5662683 | Kay | Sep 1997 | A |
5665095 | Jacobson | Sep 1997 | A |
5665122 | Kambin | Sep 1997 | A |
5667508 | Errico et al. | Sep 1997 | A |
5669915 | Caspar et al. | Sep 1997 | A |
5693100 | Pisharodi | Dec 1997 | A |
5702391 | Lin | Dec 1997 | A |
5707359 | Bufalinia | Jan 1998 | A |
5713870 | Yoon | Feb 1998 | A |
5713903 | Sander et al. | Feb 1998 | A |
5716415 | Steffee | Feb 1998 | A |
5716416 | Lin | Feb 1998 | A |
5720753 | Sander et al. | Feb 1998 | A |
5725541 | Anspach, III et al. | Mar 1998 | A |
5725588 | Errico et al. | Mar 1998 | A |
5728097 | Mathews | Mar 1998 | A |
5728116 | Rosenman | Mar 1998 | A |
5730754 | Obenchain | Mar 1998 | A |
5735853 | Olerud | Apr 1998 | A |
5741282 | Anspach, III et al. | Apr 1998 | A |
5743881 | Demco | Apr 1998 | A |
5743912 | Lahille et al. | Apr 1998 | A |
5743914 | Skiba | Apr 1998 | A |
5749889 | Bacich et al. | May 1998 | A |
5752969 | Cunci et al. | May 1998 | A |
5762500 | Lazarof | Jun 1998 | A |
5762629 | Kambin | Jun 1998 | A |
5772662 | Chapman et al. | Jun 1998 | A |
5772678 | Thomason et al. | Jun 1998 | A |
5776156 | Shikhman | Jul 1998 | A |
5782800 | Yoon | Jul 1998 | A |
5782865 | Grptz | Jul 1998 | A |
5792044 | Foley et al. | Aug 1998 | A |
5810721 | Mueller et al. | Sep 1998 | A |
5810821 | Vandewalle | Sep 1998 | A |
5810866 | Yoon | Sep 1998 | A |
5814084 | Grivas et al. | Sep 1998 | A |
5836948 | Zucherman et al. | Nov 1998 | A |
5846259 | Berthiaume | Dec 1998 | A |
5849004 | Bramlet | Dec 1998 | A |
5851216 | Allen | Dec 1998 | A |
5860977 | Zucherman et al. | Jan 1999 | A |
5865848 | Baker | Feb 1999 | A |
5871485 | Rao et al. | Feb 1999 | A |
5873854 | Wolvek | Feb 1999 | A |
5876404 | Zucherman et al. | Mar 1999 | A |
5888228 | Knothe et al. | Mar 1999 | A |
5893850 | Cachia | Apr 1999 | A |
5893889 | Harrington | Apr 1999 | A |
5895428 | Berry | Apr 1999 | A |
5902231 | Foley et al. | May 1999 | A |
5904696 | Rosenman | May 1999 | A |
5908422 | Bresina | Jun 1999 | A |
5928235 | Friedl | Jul 1999 | A |
5928244 | Tovey et al. | Jul 1999 | A |
5931870 | Cuckler et al. | Aug 1999 | A |
5935129 | McDevitt et al. | Aug 1999 | A |
5947999 | Groiso | Sep 1999 | A |
5948000 | Larsen et al. | Sep 1999 | A |
5954671 | O'Neill | Sep 1999 | A |
5954722 | Bono | Sep 1999 | A |
5954747 | Clark | Sep 1999 | A |
5957902 | Teves | Sep 1999 | A |
5957924 | Tormala et al. | Sep 1999 | A |
5964730 | Williams et al. | Oct 1999 | A |
5964761 | Kambin | Oct 1999 | A |
5967783 | Ura | Oct 1999 | A |
5967970 | Cowan et al. | Oct 1999 | A |
5968044 | Nicholson et al. | Oct 1999 | A |
5968098 | Winslow | Oct 1999 | A |
5976139 | Bramlet | Nov 1999 | A |
5976146 | Ogawa et al. | Nov 1999 | A |
5976186 | Boa et al. | Nov 1999 | A |
5980522 | Koros et al. | Nov 1999 | A |
5984926 | Jones | Nov 1999 | A |
5984927 | Wenstrom, Jr. et al. | Nov 1999 | A |
5984966 | Kiena et al. | Nov 1999 | A |
5989255 | Pepper et al. | Nov 1999 | A |
5993459 | Larsen et al. | Nov 1999 | A |
5997510 | Schwemberger | Dec 1999 | A |
5997538 | Asnis et al. | Dec 1999 | A |
5997541 | Schenk | Dec 1999 | A |
6001100 | Sherman et al. | Dec 1999 | A |
6001101 | Augagneur et al. | Dec 1999 | A |
6004327 | Asnis et al. | Dec 1999 | A |
6005161 | Brekke et al. | Dec 1999 | A |
6007519 | Rosselli | Dec 1999 | A |
6007566 | Wenstorm, Jr. | Dec 1999 | A |
6007580 | Lehto et al. | Dec 1999 | A |
6010513 | Tormala et al. | Jan 2000 | A |
6015410 | Tormala et al. | Jan 2000 | A |
6019762 | Cole | Feb 2000 | A |
6022352 | Vandewalle | Feb 2000 | A |
6030162 | Huebner | Feb 2000 | A |
6030364 | Durgin et al. | Feb 2000 | A |
6033406 | Mathews | Mar 2000 | A |
6036701 | Rosenman | Mar 2000 | A |
6048309 | Flom et al. | Apr 2000 | A |
6048342 | Zucherman et al. | Apr 2000 | A |
6053935 | Brenneman et al. | Apr 2000 | A |
6066142 | Serbousek et al. | May 2000 | A |
6068630 | Zucherman et al. | May 2000 | A |
6068648 | Cole et al. | May 2000 | A |
6080193 | Hochshuler et al. | Jun 2000 | A |
6074390 | Zucherman et al. | Jul 2000 | A |
6083244 | Lubbers et al. | Jul 2000 | A |
6090112 | Zucherman et al. | Jul 2000 | A |
6102914 | Bulstra et al. | Aug 2000 | A |
6102950 | Vaccaro | Aug 2000 | A |
6117174 | Nolan | Sep 2000 | A |
6123711 | Winters | Sep 2000 | A |
6126661 | Faccioli et al. | Oct 2000 | A |
6126663 | Hair | Oct 2000 | A |
6129762 | Li | Oct 2000 | A |
6129763 | Chauvin et al. | Oct 2000 | A |
6146384 | Lee et al. | Nov 2000 | A |
6149652 | Zucherman et al. | Nov 2000 | A |
6149669 | Li | Nov 2000 | A |
6152926 | Zucherman et al. | Nov 2000 | A |
6156038 | Zucherman et al. | Dec 2000 | A |
6156070 | Incavo et al. | Dec 2000 | A |
6159179 | Simonson | Dec 2000 | A |
6161350 | Espinosa | Dec 2000 | A |
6162234 | Freedland et al. | Dec 2000 | A |
6162236 | Osada | Dec 2000 | A |
6168595 | Durham et al. | Jan 2001 | B1 |
6168597 | Biedermann et al. | Jan 2001 | B1 |
6175758 | Kambin | Jan 2001 | B1 |
6176882 | Biedermann et al. | Jan 2001 | B1 |
6183471 | Zucherman et al. | Feb 2001 | B1 |
6183472 | Lutz | Feb 2001 | B1 |
6183474 | Bramlet et al. | Feb 2001 | B1 |
6190387 | Zucherman et al. | Feb 2001 | B1 |
6197041 | Shichman et al. | Mar 2001 | B1 |
6200322 | Branch et al. | Mar 2001 | B1 |
6206826 | Mathews et al. | Mar 2001 | B1 |
6206922 | Zdeblick et al. | Mar 2001 | B1 |
6213957 | Milliman et al. | Apr 2001 | B1 |
6217509 | Foley et al. | Apr 2001 | B1 |
6221082 | Marino et al. | Apr 2001 | B1 |
6224603 | Marino | May 2001 | B1 |
6224607 | Michaelson | May 2001 | B1 |
6228058 | Dennis et al. | May 2001 | B1 |
6231606 | Graf et al. | May 2001 | B1 |
6235030 | Zucherman et al. | May 2001 | B1 |
6238397 | Zucherman et al. | May 2001 | B1 |
6245107 | Ferree | Jun 2001 | B1 |
6248108 | Tormala et al. | Jun 2001 | B1 |
6251111 | Barker et al. | Jun 2001 | B1 |
6251140 | Marino et al. | Jun 2001 | B1 |
6264676 | Gellman et al. | Jul 2001 | B1 |
6267765 | Taylor et al. | Jul 2001 | B1 |
6267767 | Strobel et al. | Jul 2001 | B1 |
6280444 | Zucherman et al. | Aug 2001 | B1 |
6287313 | Sasso | Sep 2001 | B1 |
6290701 | Enayate | Sep 2001 | B1 |
6290724 | Marino | Sep 2001 | B1 |
6293909 | Chu et al. | Sep 2001 | B1 |
6293952 | Brosens et al. | Sep 2001 | B1 |
6306136 | Baccelli | Oct 2001 | B1 |
6319254 | Giet et al. | Nov 2001 | B1 |
6319272 | Brenneman et al. | Nov 2001 | B1 |
6332882 | Zucherman et al. | Dec 2001 | B1 |
6332883 | Zucherman et al. | Dec 2001 | B1 |
6346092 | Leschinsky | Feb 2002 | B1 |
6348053 | Cachia | Feb 2002 | B1 |
6355043 | Adam | Mar 2002 | B1 |
6361537 | Anderson | Mar 2002 | B1 |
6361538 | Fenaroli et al. | Mar 2002 | B1 |
6361557 | Houser et al. | Mar 2002 | B1 |
6364897 | Bonutti | Apr 2002 | B1 |
6368325 | McKinley et al. | Apr 2002 | B1 |
6368351 | Glenn et al. | Apr 2002 | B1 |
6371971 | Tsugita et al. | Apr 2002 | B1 |
6371989 | Chauvin et al. | Apr 2002 | B1 |
6375682 | Fleishmann et al. | Apr 2002 | B1 |
6379355 | Zucherman et al. | Apr 2002 | B1 |
6379363 | Herrington et al. | Apr 2002 | B1 |
6387130 | Stone et al. | May 2002 | B1 |
6395007 | Bhatnagar et al. | May 2002 | B1 |
6419676 | Zucherman et al. | Jul 2002 | B1 |
6419677 | Zucherman et al. | Jul 2002 | B2 |
6419704 | Ferree | Jul 2002 | B1 |
6423061 | Bryant | Jul 2002 | B1 |
6423067 | Eisermann | Jul 2002 | B1 |
6425919 | Lambrecht | Jul 2002 | B1 |
6428541 | Boyd et al. | Aug 2002 | B1 |
6428556 | Chin | Aug 2002 | B1 |
6436143 | Ross et al. | Aug 2002 | B1 |
6440154 | Gellman | Aug 2002 | B2 |
6440169 | Elberg et al. | Aug 2002 | B1 |
6443989 | Jackson | Sep 2002 | B1 |
6447527 | Thompson et al. | Sep 2002 | B1 |
6447540 | Fontaine et al. | Sep 2002 | B1 |
6450989 | Dubrul et al. | Sep 2002 | B2 |
6451019 | Zucherman et al. | Sep 2002 | B1 |
6451020 | Zucherman et al. | Sep 2002 | B1 |
6454807 | Jackson | Sep 2002 | B1 |
6458134 | Songer et al. | Oct 2002 | B1 |
6468277 | Justin et al. | Oct 2002 | B1 |
6468309 | Lieberman | Oct 2002 | B1 |
6468310 | Ralph et al. | Oct 2002 | B1 |
6471724 | Zdeblick et al. | Oct 2002 | B2 |
6475226 | Belef et al. | Nov 2002 | B1 |
6478029 | Boyd et al. | Nov 2002 | B1 |
6478796 | Boyd et al. | Nov 2002 | B2 |
6485491 | Farris et al. | Nov 2002 | B1 |
6485518 | Cornwall et al. | Nov 2002 | B1 |
6488693 | Gannoe et al. | Dec 2002 | B2 |
6491714 | Bennett | Dec 2002 | B1 |
6494860 | Rocamora et al. | Dec 2002 | B2 |
6494893 | Dubrul et al. | Dec 2002 | B2 |
6500178 | Zucherman et al. | Dec 2002 | B2 |
6506192 | Gertzman et al. | Jan 2003 | B1 |
6511481 | von Hoffmann et al. | Jan 2003 | B2 |
6514256 | Zucherman et al. | Feb 2003 | B2 |
6517543 | Berrevoets et al. | Feb 2003 | B1 |
6520907 | Foley et al. | Feb 2003 | B1 |
6527774 | Lieberman | Mar 2003 | B2 |
6540747 | Marino | Apr 2003 | B1 |
6544265 | Lieberman | Apr 2003 | B2 |
6547793 | McGuire | Apr 2003 | B1 |
6547795 | Schneiderman | Apr 2003 | B2 |
6551319 | Lieberman | Apr 2003 | B2 |
6551322 | Lieberman | Apr 2003 | B1 |
6554831 | Rivard et al. | Apr 2003 | B1 |
6554852 | Oberlander | Apr 2003 | B1 |
6558389 | Clark et al. | May 2003 | B2 |
6562046 | Sasso | May 2003 | B2 |
6562049 | Norlander et al. | May 2003 | B1 |
6562074 | Gerbec et al. | May 2003 | B2 |
6575979 | Cragg | Jun 2003 | B1 |
6576016 | Hochshuler et al. | Jun 2003 | B1 |
6579293 | Chandran | Jun 2003 | B1 |
6582390 | Sanderson | Jun 2003 | B1 |
6582431 | Ray | Jun 2003 | B1 |
6582433 | Yun | Jun 2003 | B2 |
6582441 | He et al. | Jun 2003 | B1 |
6582453 | Tran et al. | Jun 2003 | B1 |
6582437 | Dorchak et al. | Jul 2003 | B2 |
6585730 | Foerster | Jul 2003 | B1 |
6585740 | Schlapfer et al. | Jul 2003 | B2 |
6589240 | Hinchliffe | Jul 2003 | B2 |
6589249 | Sater et al. | Jul 2003 | B2 |
6592553 | Zhang et al. | Jul 2003 | B2 |
6595998 | Johnson et al. | Jul 2003 | B2 |
6596008 | Kambin | Jul 2003 | B1 |
6599297 | Carlsson et al. | Jul 2003 | B1 |
6607530 | Carl et al. | Aug 2003 | B1 |
6610091 | Reiley | Aug 2003 | B1 |
6613050 | Wagner et al. | Sep 2003 | B1 |
6616678 | Nishtala et al. | Sep 2003 | B2 |
6620196 | Trieu | Sep 2003 | B1 |
6626944 | Taylor | Sep 2003 | B1 |
6632224 | Cachia et al. | Oct 2003 | B2 |
6635059 | Randall et al. | Oct 2003 | B2 |
6635362 | Ray, III et al. | Oct 2003 | B2 |
6648890 | Culbert et al. | Nov 2003 | B2 |
6648893 | Dudasik | Nov 2003 | B2 |
6652527 | Zucherman et al. | Nov 2003 | B2 |
6655962 | Kennard | Dec 2003 | B1 |
6666891 | Boehm, Jr. et al. | Dec 2003 | B2 |
6669698 | Tromanhauser et al. | Dec 2003 | B1 |
6669729 | Chin | Dec 2003 | B2 |
6673074 | Shluzas | Jan 2004 | B2 |
6676664 | Al-Assir | Jan 2004 | B1 |
6679833 | Smith et al. | Jan 2004 | B2 |
6682535 | Hoogland | Jan 2004 | B2 |
6685706 | Padget et al. | Feb 2004 | B2 |
6685742 | Jackson | Feb 2004 | B1 |
6689152 | Balceta et al. | Feb 2004 | B2 |
6692499 | Tormalaet et al. | Feb 2004 | B2 |
6695842 | Zucherman et al. | Feb 2004 | B2 |
6695851 | Zdeblick et al. | Feb 2004 | B2 |
6699246 | Zucherman et al. | Mar 2004 | B2 |
6699247 | Zucherman et al. | Mar 2004 | B2 |
6712819 | Zucherman et al. | Mar 2004 | B2 |
6716247 | Michelson | Apr 2004 | B2 |
6719760 | Dorchak et al. | Apr 2004 | B2 |
6723096 | Dorchak et al. | Apr 2004 | B1 |
6723126 | Berry | Apr 2004 | B1 |
6730126 | Boehm, Jr. et al. | May 2004 | B2 |
6733496 | Sharkey et al. | May 2004 | B2 |
6733534 | Sherman | May 2004 | B2 |
6733535 | Michelson | May 2004 | B2 |
6733635 | Ozawa et al. | May 2004 | B1 |
6740090 | Cragg et al. | May 2004 | B1 |
6740093 | Hoschchuler et al. | May 2004 | B2 |
6743166 | Berci et al. | Jun 2004 | B2 |
6746451 | Middleton et al. | Jun 2004 | B2 |
6752831 | Sybert et al. | Jun 2004 | B2 |
6761720 | Senegas | Jul 2004 | B1 |
6764491 | Frey et al. | Jul 2004 | B2 |
6770075 | Howland | Aug 2004 | B2 |
6773460 | Jackson | Aug 2004 | B2 |
6790210 | Cragg et al. | Sep 2004 | B1 |
6793656 | Mathews | Sep 2004 | B1 |
6796983 | Zucherman et al. | Sep 2004 | B1 |
6805695 | Keith | Oct 2004 | B2 |
6808526 | Magerl et al. | Oct 2004 | B1 |
6808537 | Michelson | Oct 2004 | B2 |
6821298 | Jackson | Nov 2004 | B1 |
6830570 | Frey et al. | Dec 2004 | B1 |
6830589 | Erikson | Dec 2004 | B2 |
6835205 | Atkinson et al. | Dec 2004 | B2 |
6835206 | Jackson | Dec 2004 | B2 |
6843804 | Bryan | Jan 2005 | B2 |
6852126 | Ahlgren | Feb 2005 | B2 |
6875215 | Taras et al. | Apr 2005 | B2 |
6887243 | Culbert et al. | May 2005 | B2 |
6890333 | von Hoffmann et al. | May 2005 | B2 |
6893466 | Trieu | May 2005 | B2 |
6902566 | Zucherman et al. | Jun 2005 | B2 |
6908465 | von Hoffmann et al. | Jun 2005 | B2 |
6916323 | Kitchens et al. | Jun 2005 | B2 |
6921403 | Cragg et al. | Jun 2005 | B2 |
6923811 | Carl et al. | Aug 2005 | B1 |
6929606 | Ritland | Aug 2005 | B2 |
6932820 | Osman | Aug 2005 | B2 |
6936072 | Lambrecht et al. | Aug 2005 | B2 |
6942668 | Padget et al. | Sep 2005 | B2 |
6945975 | Dalton | Sep 2005 | B2 |
6946000 | Senegas et al. | Sep 2005 | B2 |
6949100 | Venturini | Sep 2005 | B1 |
6951561 | Warren et al. | Oct 2005 | B2 |
6972035 | Michelson | Dec 2005 | B2 |
6974478 | Reiley et al. | Dec 2005 | B2 |
6997929 | Manzi et al. | Feb 2006 | B2 |
7004945 | Boyd et al. | Feb 2006 | B2 |
7018415 | McKay | Mar 2006 | B1 |
7025746 | Tal | Apr 2006 | B2 |
7029473 | Zucherman et al. | Apr 2006 | B2 |
7041107 | Pohjonen et al. | May 2006 | B2 |
7048736 | Zucherman et al. | May 2006 | B2 |
7109977 | Pohjonen et al. | May 2006 | B2 |
7060068 | Tromanhauser et al. | Jun 2006 | B2 |
7063701 | Michelson | Jun 2006 | B2 |
7063702 | Michelson | Jun 2006 | B2 |
7066960 | Zucherman et al. | Jun 2006 | B1 |
7066961 | Michelson | Jun 2006 | B2 |
7070601 | Culbert et al. | Jul 2006 | B2 |
7074203 | Johanson et al. | Jul 2006 | B1 |
7087083 | Zucherman et al. | Aug 2006 | B2 |
7087087 | Boyer, II et al. | Aug 2006 | B2 |
7094239 | Michelson | Aug 2006 | B1 |
7094257 | Mujwid et al. | Aug 2006 | B2 |
7094258 | Lambrecht et al. | Aug 2006 | B2 |
7101375 | Zucherman et al. | Sep 2006 | B2 |
7114501 | Johnson et al. | Oct 2006 | B2 |
7118572 | Bramlet et al. | Oct 2006 | B2 |
7118579 | Michelson | Oct 2006 | B2 |
7118598 | Michelson | Oct 2006 | B2 |
7128760 | Michelson | Oct 2006 | B2 |
7153305 | Johnson et al. | Dec 2006 | B2 |
D536096 | Hoogland et al. | Jan 2007 | S |
7163558 | Senegas et al. | Jan 2007 | B2 |
7172612 | Ishikawa | Feb 2007 | B2 |
7179294 | Eisermann et al. | Feb 2007 | B2 |
7201751 | Zucherman et al. | Apr 2007 | B2 |
7226481 | Kuslich | Jun 2007 | B2 |
7261738 | Casey | Jun 2007 | B2 |
7238204 | Couedic et al. | Jul 2007 | B2 |
7267683 | Sharkey et al. | Sep 2007 | B2 |
7282061 | Sharkey et al. | Oct 2007 | B2 |
7306628 | Zucherman et al. | Dec 2007 | B2 |
7309336 | Ashley et al. | Dec 2007 | B2 |
7309357 | Kim | Dec 2007 | B2 |
7318839 | Malbert et al. | Jan 2008 | B2 |
7320688 | Foley et al. | Jan 2008 | B2 |
7335203 | Winslow et al. | Feb 2008 | B2 |
7361140 | Ries et al. | Apr 2008 | B2 |
7361193 | Frey et al. | Apr 2008 | B2 |
7371238 | Soboleski et al. | May 2008 | B2 |
7377942 | Berry | May 2008 | B2 |
7400930 | Sharkey et al. | Jul 2008 | B2 |
7326211 | Padget et al. | Aug 2008 | B2 |
7410501 | Michelson | Aug 2008 | B2 |
7413576 | Sybert et al. | Aug 2008 | B2 |
7422594 | Zander | Sep 2008 | B2 |
7434325 | Foley et al. | Oct 2008 | B2 |
7445636 | Michelson | Nov 2008 | B2 |
7445637 | Taylor | Nov 2008 | B2 |
D584812 | Ries | Jan 2009 | S |
7473256 | Assell et al. | Jan 2009 | B2 |
7473268 | Zucherman et al. | Jan 2009 | B2 |
7476251 | Zucherman et al. | Jan 2009 | B2 |
7481812 | Frey et al. | Jan 2009 | B2 |
7488326 | Elliott | Feb 2009 | B2 |
7520888 | Trieu | Apr 2009 | B2 |
7534269 | Casey | May 2009 | B2 |
7547317 | Cragg | Jun 2009 | B2 |
7556629 | von Hoffmann et al. | Jul 2009 | B2 |
7556651 | Humphreys et al. | Jul 2009 | B2 |
7588574 | Assell et al. | Sep 2009 | B2 |
7625378 | Foley | Dec 2009 | B2 |
7641657 | Cragg | Jan 2010 | B2 |
7641670 | Davison et al. | Jan 2010 | B2 |
7647123 | Sharkey et al. | Jan 2010 | B2 |
7648523 | Mirkovic et al. | Jan 2010 | B2 |
7655012 | DiPoto et al. | Feb 2010 | B2 |
7670354 | Davison et al. | Mar 2010 | B2 |
7674273 | Davison et al. | Mar 2010 | B2 |
7682370 | Pagliuca et al. | Mar 2010 | B2 |
7690381 | Bartish, Jr. et al. | Apr 2010 | B2 |
7691120 | Shluzas et al. | Apr 2010 | B2 |
7699878 | Pavlov et al. | Apr 2010 | B2 |
7715284 | Culbert | May 2010 | B2 |
7717944 | Foley et al. | May 2010 | B2 |
7722530 | Davison | May 2010 | B2 |
7727263 | Cragg | Jun 2010 | B2 |
7740633 | Assell et al. | Jun 2010 | B2 |
7744599 | Cragg | Jun 2010 | B2 |
7762995 | Eversull et al. | Jul 2010 | B2 |
7763025 | Assell et al. | Jul 2010 | B2 |
7763055 | Foley | Jul 2010 | B2 |
7766930 | DiPoto et al. | Aug 2010 | B2 |
7771479 | Humphreys et al. | Aug 2010 | B2 |
7776094 | McKinley et al. | Aug 2010 | B2 |
7794463 | Cragg | Sep 2010 | B2 |
7799032 | Assell et al. | Sep 2010 | B2 |
7799033 | Assell et al. | Sep 2010 | B2 |
7799034 | Johnson et al. | Sep 2010 | B2 |
7799036 | Davison et al. | Sep 2010 | B2 |
D626233 | Cipoletti et al. | Oct 2010 | S |
7814429 | Buffet et al. | Oct 2010 | B2 |
7819921 | Grotz | Oct 2010 | B2 |
7824410 | Simonson et al. | Nov 2010 | B2 |
7824429 | Culbert et al. | Nov 2010 | B2 |
7837734 | Zucheman et al. | Nov 2010 | B2 |
7846183 | Blain | Dec 2010 | B2 |
7850695 | Pagliuca et al. | Dec 2010 | B2 |
7850733 | Baynham | Dec 2010 | B2 |
7857832 | Culbert et al. | Dec 2010 | B2 |
7862590 | Lim et al. | Jan 2011 | B2 |
7862595 | Foley et al. | Jan 2011 | B2 |
7867259 | Foley et al. | Jan 2011 | B2 |
7875077 | Humphreys et al. | Jan 2011 | B2 |
7887548 | Usher, Jr. et al. | Feb 2011 | B2 |
7887589 | Glenn | Feb 2011 | B2 |
7892171 | Davison et al. | Feb 2011 | B2 |
7892249 | Davison et al. | Feb 2011 | B2 |
7901438 | Culbert et al. | Mar 2011 | B2 |
7901459 | Hodges et al. | Mar 2011 | B2 |
7909848 | Patel et al. | Mar 2011 | B2 |
7931689 | Hochschuler et al. | Apr 2011 | B2 |
7938832 | Culbert et al. | May 2011 | B2 |
7972382 | Foley et al. | Jul 2011 | B2 |
7993377 | Culbert et al. | Aug 2011 | B2 |
7998176 | Culbert | Aug 2011 | B2 |
8062375 | Glerum | Nov 2011 | B2 |
8105382 | Olmos et al. | Jan 2012 | B2 |
8109977 | Culbert et al. | Feb 2012 | B2 |
8133232 | Levy | Mar 2012 | B2 |
8137404 | Lopez et al. | Mar 2012 | B2 |
8147549 | Metcalf, Jr. et al. | Apr 2012 | B2 |
8157845 | Wamick et al. | Apr 2012 | B2 |
8216316 | Kirschman | Jul 2012 | B2 |
8252060 | Hansell et al. | Aug 2012 | B2 |
8262736 | Michelson | Sep 2012 | B2 |
8273129 | Baynham | Sep 2012 | B2 |
8317866 | Palmatier | Nov 2012 | B2 |
8343189 | Assell et al. | Jan 2013 | B2 |
8366777 | Matthis | Feb 2013 | B2 |
8394107 | Fanger et al. | Mar 2013 | B2 |
8394129 | Lopez et al. | Mar 2013 | B2 |
8398713 | Weiman | Mar 2013 | B2 |
8518087 | Morgenstern et al. | Aug 2013 | B2 |
8551092 | Morgan et al. | Oct 2013 | B2 |
8551094 | Hoffmann et al. | Oct 2013 | B2 |
8556949 | Teisen et al. | Oct 2013 | B2 |
8568481 | Olmos et al. | Oct 2013 | B2 |
8597333 | Morgenstern et al. | Dec 2013 | B2 |
8623021 | Ries et al. | Jan 2014 | B2 |
8652183 | Truman | Feb 2014 | B1 |
8696716 | Kartalian et al. | Apr 2014 | B2 |
8709088 | Kleiner et al. | Apr 2014 | B2 |
8715014 | Culbert | May 2014 | B2 |
8852242 | Lopez et al. | Oct 2014 | B2 |
8852243 | Lopez et al. | Oct 2014 | B2 |
8926704 | Glerum et al. | Jan 2015 | B2 |
8945190 | Culbert et al. | Feb 2015 | B2 |
20010012950 | Nishtala et al. | Aug 2001 | A1 |
20010027320 | Sasso | Oct 2001 | A1 |
20010037126 | Stack et al. | Nov 2001 | A1 |
20010039452 | Zucherman et al. | Nov 2001 | A1 |
20010049529 | Cachia et al. | Dec 2001 | A1 |
20010049530 | Culbert et al. | Dec 2001 | A1 |
20020001476 | Nagamine et al. | Jan 2002 | A1 |
20020032462 | Houser et al. | Mar 2002 | A1 |
20020055740 | Lieberman | May 2002 | A1 |
20020087152 | Mikus et al. | Jul 2002 | A1 |
20020091387 | Hoogland | Jul 2002 | A1 |
20020120335 | Angelucci et al. | Aug 2002 | A1 |
20020143331 | Zucherman et al. | Oct 2002 | A1 |
20020161444 | Choi | Oct 2002 | A1 |
20020183848 | Ray et al. | Dec 2002 | A1 |
20030004528 | Ishikawa | Jan 2003 | A1 |
20030004575 | Erickson | Jan 2003 | A1 |
20030028250 | Reiley et al. | Feb 2003 | A1 |
20030028251 | Mathews | Feb 2003 | A1 |
20030063582 | Culbert | Apr 2003 | A1 |
20030065330 | Zucherman et al. | Apr 2003 | A1 |
20030065396 | Michelson | Apr 2003 | A1 |
20030083688 | Simonson | May 2003 | A1 |
20030139648 | Foley et al. | Jul 2003 | A1 |
20030139813 | Messerli et al. | Jul 2003 | A1 |
20030187431 | Simonson | Oct 2003 | A1 |
20030208122 | Melkent et al. | Nov 2003 | A1 |
20030208220 | Worley et al. | Nov 2003 | A1 |
20030220643 | Ferree | Nov 2003 | A1 |
20030229350 | Kay | Dec 2003 | A1 |
20030233102 | Nakamura et al. | Dec 2003 | A1 |
20040006391 | Reiley | Jan 2004 | A1 |
20040008949 | Culbert | Jan 2004 | A1 |
20040019359 | Worley et al. | Jan 2004 | A1 |
20040024463 | Thomas et al. | Feb 2004 | A1 |
20040039400 | Schmeiding et al. | Feb 2004 | A1 |
20040049190 | Biedermann et al. | Mar 2004 | A1 |
20040049223 | Nishtala et al. | Mar 2004 | A1 |
20040054412 | Gerbec et al. | Mar 2004 | A1 |
20040059339 | Roehm et al. | Mar 2004 | A1 |
20040059350 | Gordon et al. | Mar 2004 | A1 |
20040097924 | Lambrecht et al. | May 2004 | A1 |
20040097941 | Weiner et al. | May 2004 | A1 |
20040097973 | Loshakove et al. | May 2004 | A1 |
20040106925 | Culbert | Jun 2004 | A1 |
20040106999 | Mathews | Jun 2004 | A1 |
20040127906 | Culbert et al. | Jul 2004 | A1 |
20040133280 | Trieu | Jul 2004 | A1 |
20040143284 | Chin | Jul 2004 | A1 |
20040143734 | Buer et al. | Jul 2004 | A1 |
20040147877 | Heuser | Jul 2004 | A1 |
20040147950 | Mueller et al. | Jul 2004 | A1 |
20040153156 | Cohen | Aug 2004 | A1 |
20040158258 | Bonati et al. | Aug 2004 | A1 |
20040162617 | Zucherman et al. | Aug 2004 | A1 |
20040172134 | Berry | Sep 2004 | A1 |
20040181231 | Emstad et al. | Sep 2004 | A1 |
20040186471 | Trieu | Sep 2004 | A1 |
20040186482 | Kolb et al. | Sep 2004 | A1 |
20040215343 | Hochschuler et al. | Oct 2004 | A1 |
20040215344 | Hochschuler et al. | Oct 2004 | A1 |
20040220580 | Johnson et al. | Nov 2004 | A1 |
20040225292 | Sasso et al. | Nov 2004 | A1 |
20040225361 | Glenn et al. | Nov 2004 | A1 |
20040243239 | Taylor | Dec 2004 | A1 |
20040249466 | Liu et al. | Dec 2004 | A1 |
20040254575 | Obenchain et al. | Dec 2004 | A1 |
20040260297 | Padget et al. | Dec 2004 | A1 |
20040266257 | Ries et al. | Dec 2004 | A1 |
20050021031 | Foley et al. | Jan 2005 | A1 |
20050033434 | Berry | Feb 2005 | A1 |
20050043796 | Grant et al. | Feb 2005 | A1 |
20050065610 | Pisharodi | Mar 2005 | A1 |
20050080443 | Fallin et al. | Apr 2005 | A1 |
20050085917 | Marnay et al. | Apr 2005 | A1 |
20050090833 | Di Poto | Apr 2005 | A1 |
20050090899 | DiPoto | Apr 2005 | A1 |
20050102202 | Linden et al. | May 2005 | A1 |
20050113927 | Malek | May 2005 | A1 |
20050118550 | Turri | Jun 2005 | A1 |
20050119657 | Goldsmith | Jun 2005 | A1 |
20050130929 | Boyd | Jun 2005 | A1 |
20050131406 | Reiley et al. | Jun 2005 | A1 |
20050131409 | Chervitz et al. | Jun 2005 | A1 |
20050131538 | Chervitz et al. | Jun 2005 | A1 |
20050137595 | von Hoffmann et al. | Jun 2005 | A1 |
20050143734 | Cachia et al. | Jun 2005 | A1 |
20050149030 | Serhan | Jul 2005 | A1 |
20050154467 | Peterman et al. | Jul 2005 | A1 |
20050165398 | Reiley | Jul 2005 | A1 |
20050171552 | Johnson et al. | Aug 2005 | A1 |
20050171608 | Peterman et al. | Aug 2005 | A1 |
20050171610 | Humphreys et al. | Aug 2005 | A1 |
20050182414 | Manzi et al. | Aug 2005 | A1 |
20050182418 | Boyd et al. | Aug 2005 | A1 |
20050187558 | Johnson et al. | Aug 2005 | A1 |
20050187559 | Raymond et al. | Aug 2005 | A1 |
20050203512 | Hawkins et al. | Sep 2005 | A1 |
20050216026 | Culbert | Sep 2005 | A1 |
20050222681 | Richley et al. | Oct 2005 | A1 |
20050251142 | von Hoffmann et al. | Nov 2005 | A1 |
20050256525 | Culbert et al. | Nov 2005 | A1 |
20050278026 | Gordon et al. | Dec 2005 | A1 |
20050283238 | Reiley | Dec 2005 | A1 |
20060004326 | Collins et al. | Jan 2006 | A1 |
20060004398 | Binder et al. | Jan 2006 | A1 |
20060004457 | Collins et al. | Jan 2006 | A1 |
20060004458 | Collins et al. | Jan 2006 | A1 |
20060009778 | Collins et al. | Jan 2006 | A1 |
20060009779 | Collins et al. | Jan 2006 | A1 |
20060009851 | Collins et al. | Jan 2006 | A1 |
20060015105 | Warren et al. | Jan 2006 | A1 |
20060030872 | Culbert et al. | Feb 2006 | A1 |
20060036241 | Siegal | Feb 2006 | A1 |
20060036246 | Carl et al. | Feb 2006 | A1 |
20060036256 | Carl et al. | Feb 2006 | A1 |
20060036259 | Carl et al. | Feb 2006 | A1 |
20060036323 | Carl et al. | Feb 2006 | A1 |
20060036324 | Sachs et al. | Feb 2006 | A1 |
20060041314 | Millard | Feb 2006 | A1 |
20060047296 | Embry et al. | Mar 2006 | A1 |
20060058790 | Carl et al. | Mar 2006 | A1 |
20060058807 | Landry et al. | Mar 2006 | A1 |
20060058880 | Wysocki et al. | Mar 2006 | A1 |
20060079908 | Lieberman | Apr 2006 | A1 |
20060084977 | Lieberman | Apr 2006 | A1 |
20060084988 | Kim | Apr 2006 | A1 |
20060085010 | Lieberman | Apr 2006 | A1 |
20060089642 | Diaz | Apr 2006 | A1 |
20060100707 | Stinson et al. | May 2006 | A1 |
20060106381 | Ferree et al. | May 2006 | A1 |
20060111714 | Foley | May 2006 | A1 |
20060119629 | An et al. | Jun 2006 | A1 |
20060122609 | Mirkovic et al. | Jun 2006 | A1 |
20060122610 | Culbert et al. | Jun 2006 | A1 |
20060129244 | Ensign | Jun 2006 | A1 |
20060142765 | Dixon et al. | Jun 2006 | A9 |
20060142776 | Iwanari | Jun 2006 | A1 |
20060161166 | Johnson et al. | Jul 2006 | A1 |
20060178743 | Carter | Aug 2006 | A1 |
20060178745 | Bartish et al. | Aug 2006 | A1 |
20060178746 | Bartish, Jr. et al. | Aug 2006 | A1 |
20060195103 | Padget et al. | Aug 2006 | A1 |
20060200186 | Schmieding et al. | Sep 2006 | A1 |
20060217711 | Stevens et al. | Sep 2006 | A1 |
20060229629 | Manzi et al. | Oct 2006 | A1 |
20060229725 | Lechmann et al. | Oct 2006 | A1 |
20060235403 | Blain | Oct 2006 | A1 |
20060235410 | Ralph | Oct 2006 | A1 |
20060235412 | Blain | Oct 2006 | A1 |
20060247634 | Warner et al. | Nov 2006 | A1 |
20060247778 | Ferree | Nov 2006 | A1 |
20060276899 | Zipnick et al. | Dec 2006 | A1 |
20060276901 | Zipnick et al. | Dec 2006 | A1 |
20060276902 | Zipnick et al. | Dec 2006 | A1 |
20060293662 | Boyer, II et al. | Dec 2006 | A1 |
20060293663 | Walkenhorst et al. | Dec 2006 | A1 |
20070010826 | Rhoda | Jan 2007 | A1 |
20070016191 | Culbert et al. | Jan 2007 | A1 |
20070032790 | Aschmann et al. | Feb 2007 | A1 |
20070055236 | Hudgins et al. | Mar 2007 | A1 |
20070067035 | Falahee | Mar 2007 | A1 |
20070073399 | Zipnick et al. | Mar 2007 | A1 |
20070093841 | Hooglad | Apr 2007 | A1 |
20070118132 | Culbert et al. | May 2007 | A1 |
20070118223 | Allard et al. | May 2007 | A1 |
20070123868 | Culbert et al. | May 2007 | A1 |
20070123891 | Ries et al. | May 2007 | A1 |
20070123892 | Ries et al. | May 2007 | A1 |
20070129730 | Woods et al. | Jun 2007 | A1 |
20070162005 | Peterson et al. | Jul 2007 | A1 |
20070168036 | Ainsworth et al. | Jul 2007 | A1 |
20070185491 | Foley et al. | Aug 2007 | A1 |
20070203491 | Pasquet et al. | Aug 2007 | A1 |
20070233083 | Abdou | Oct 2007 | A1 |
20070233089 | DiPoto et al. | Oct 2007 | A1 |
20070233244 | Lopez et al. | Oct 2007 | A1 |
20070233253 | Bray et al. | Oct 2007 | A1 |
20070260248 | Tipirneni | Nov 2007 | A1 |
20070260314 | Biyani | Nov 2007 | A1 |
20070260318 | Lawson | Nov 2007 | A1 |
20070270954 | Wu | Nov 2007 | A1 |
20070270968 | Baynham et al. | Nov 2007 | A1 |
20070282449 | de Villiers | Dec 2007 | A1 |
20080015699 | Voydeville | Jan 2008 | A1 |
20080015703 | Casey | Jan 2008 | A1 |
20080039842 | Sweeney | Feb 2008 | A1 |
20080058598 | Ries et al. | Mar 2008 | A1 |
20080077148 | Ries et al. | Mar 2008 | A1 |
20080082172 | Jackson | Apr 2008 | A1 |
20080097436 | Culbert et al. | Apr 2008 | A1 |
20080108996 | Padget et al. | May 2008 | A1 |
20080125864 | deVilliers et al. | May 2008 | A1 |
20080140207 | Olmos et al. | Jun 2008 | A1 |
20080147193 | Matthis et al. | Jun 2008 | A1 |
20080177334 | Stinnette | Jul 2008 | A1 |
20080221623 | Gooch | Sep 2008 | A1 |
20080255618 | Fisher et al. | Oct 2008 | A1 |
20080262619 | Ray | Oct 2008 | A1 |
20080287981 | Culbert et al. | Nov 2008 | A1 |
20080287997 | Altarac et al. | Nov 2008 | A1 |
20080300685 | Carls et al. | Dec 2008 | A1 |
20080306481 | Farr et al. | Dec 2008 | A1 |
20080306537 | Culbert et al. | Dec 2008 | A1 |
20090005870 | Hawkins et al. | Jan 2009 | A1 |
20090036893 | Kartalian et al. | Feb 2009 | A1 |
20090062807 | Song | Mar 2009 | A1 |
20090069813 | von Hoffmann et al. | Mar 2009 | A1 |
20090131986 | Lee et al. | Mar 2009 | A1 |
20090093885 | Levieux et al. | Apr 2009 | A1 |
20090099610 | Johnson et al. | Apr 2009 | A1 |
20090105745 | Culbert et al. | Apr 2009 | A1 |
20090149857 | Culbert et al. | Jun 2009 | A1 |
20090182429 | Humphreys et al. | Jul 2009 | A1 |
20090187246 | Foley | Jul 2009 | A1 |
20090222100 | Cipoletti et al. | Sep 2009 | A1 |
20090240335 | Arcenio et al. | Sep 2009 | A1 |
20090275890 | Leibowitz et al. | Nov 2009 | A1 |
20090292361 | Lopez | Nov 2009 | A1 |
20100016973 | de Villiers et al. | Jan 2010 | A1 |
20100040332 | Culbert et al. | Feb 2010 | A1 |
20100076492 | Warner et al. | Mar 2010 | A1 |
20100082109 | Greenhalgh | Apr 2010 | A1 |
20100114147 | Biyani | May 2010 | A1 |
20100161062 | Foley et al. | Jun 2010 | A1 |
20100174314 | Mirkovic | Jul 2010 | A1 |
20100191336 | Greenhalgh | Jul 2010 | A1 |
20100211176 | Greenhalgh | Aug 2010 | A1 |
20100217330 | Phan et al. | Aug 2010 | A1 |
20100268228 | Petersen | Oct 2010 | A1 |
20100268231 | Kuslich | Oct 2010 | A1 |
20100268341 | Dvorak et al. | Oct 2010 | A1 |
20100286787 | Villiers et al. | Nov 2010 | A1 |
20100292700 | Ries | Nov 2010 | A1 |
20100292796 | Greenhalgh et al. | Nov 2010 | A1 |
20100298938 | Humphreys et al. | Nov 2010 | A1 |
20100318134 | Roche et al. | Dec 2010 | A1 |
20100331891 | Culbert et al. | Dec 2010 | A1 |
20110054538 | Zehavi et al. | Mar 2011 | A1 |
20110071527 | Nelson et al. | Mar 2011 | A1 |
20110087296 | Reiley et al. | Apr 2011 | A1 |
20110098531 | To | Apr 2011 | A1 |
20110098628 | Yeung et al. | Apr 2011 | A1 |
20110130838 | Lopez | Jun 2011 | A1 |
20110137421 | Hansell et al. | Jun 2011 | A1 |
20110144687 | Kleiner | Jun 2011 | A1 |
20110144766 | Kale et al. | Jun 2011 | A1 |
20110153020 | Abdelgany | Jun 2011 | A1 |
20110172774 | Varela | Jul 2011 | A1 |
20110208226 | Fatone et al. | Aug 2011 | A1 |
20110218575 | Culbert et al. | Sep 2011 | A1 |
20110230965 | Schell et al. | Sep 2011 | A1 |
20110238072 | Tyndall | Sep 2011 | A1 |
20110251690 | Berger et al. | Oct 2011 | A1 |
20110264147 | Culbert | Oct 2011 | A1 |
20110282453 | Greenhalgh | Nov 2011 | A1 |
20110307010 | Pradhan | Dec 2011 | A1 |
20110313465 | Warren et al. | Dec 2011 | A1 |
20110319997 | Glerum et al. | Dec 2011 | A1 |
20120004732 | Goel et al. | Jan 2012 | A1 |
20120006361 | Glerum | Jan 2012 | A1 |
20120059474 | Weiman | Mar 2012 | A1 |
20120059475 | Weiman | Mar 2012 | A1 |
20120059480 | Schell et al. | Mar 2012 | A1 |
20120065734 | Barrett et al. | Mar 2012 | A1 |
20120071978 | Suedkamp et al. | Mar 2012 | A1 |
20120089228 | Poulos | Apr 2012 | A1 |
20120150304 | Glerum | Jun 2012 | A1 |
20120150305 | Glerum | Jun 2012 | A1 |
20120158146 | Glerum | Jun 2012 | A1 |
20120158147 | Glerum | Jun 2012 | A1 |
20120158148 | Glerum | Jun 2012 | A1 |
20120185049 | Varela | Jul 2012 | A1 |
20120191194 | Olmos et al. | Jul 2012 | A1 |
20120197405 | Cuevas | Aug 2012 | A1 |
20120203290 | Warren et al. | Aug 2012 | A1 |
20120203347 | Glerum | Aug 2012 | A1 |
20120209386 | Triplett et al. | Aug 2012 | A1 |
20120215262 | Culbert et al. | Aug 2012 | A1 |
20120226357 | Varela | Sep 2012 | A1 |
20120232552 | Lopez et al. | Sep 2012 | A1 |
20120232658 | Lopez et al. | Sep 2012 | A1 |
20120265309 | Glerum | Oct 2012 | A1 |
20120277864 | Brodke et al. | Nov 2012 | A1 |
20120290090 | Glerum | Nov 2012 | A1 |
20120290091 | Kirschman | Nov 2012 | A1 |
20120290097 | Cipoletti | Nov 2012 | A1 |
20120303039 | Chin et al. | Nov 2012 | A1 |
20120323328 | Weiman | Dec 2012 | A1 |
20120330421 | Weiman | Dec 2012 | A1 |
20120330422 | Weiman | Dec 2012 | A1 |
20130006361 | Glerum et al. | Jan 2013 | A1 |
20130023993 | Weiman | Jan 2013 | A1 |
20130023994 | Glerum | Jan 2013 | A1 |
20130053894 | Gamache et al. | Feb 2013 | A1 |
20130096634 | Suh | Apr 2013 | A1 |
20130190769 | Lopez | Jul 2013 | A1 |
20130197642 | Ernst | Aug 2013 | A1 |
20130231747 | Olmos | Sep 2013 | A1 |
20130245703 | Warren | Sep 2013 | A1 |
20140067069 | Lopez | Mar 2014 | A1 |
20140142629 | Hoffmann | May 2014 | A1 |
20140236296 | Wagner et al. | Aug 2014 | A1 |
20140257296 | Lopez | Sep 2014 | A1 |
20140257484 | Flower | Sep 2014 | A1 |
20140257489 | Warren | Sep 2014 | A1 |
20140277204 | Sandhu | Sep 2014 | A1 |
20140277473 | Perrow | Sep 2014 | A1 |
20140371532 | Trovato | Dec 2014 | A1 |
20150018891 | Culbert | Jan 2015 | A1 |
20150094610 | Lopez | Apr 2015 | A1 |
Number | Date | Country |
---|---|---|
3 023 353 | Apr 1981 | DE |
197 00 474 | Jul 1998 | DE |
198 32 798 | Nov 1999 | DE |
201 01 793 | May 2001 | DE |
0 077 159 | Apr 1983 | EP |
0 260 044 | Mar 1988 | EP |
0 525 352 | Feb 1993 | EP |
0 611 557 | Aug 1994 | EP |
0 625 336 | Nov 1994 | EP |
0 433 717 | Jun 1997 | EP |
1 046 376 | Apr 2000 | EP |
0 853 929 | Sep 2002 | EP |
1 378 205 | Jul 2003 | EP |
1 374 784 | Jan 2004 | EP |
1 676 538 | Jul 2006 | EP |
1 757 529 | Feb 2007 | EP |
1 864 616 | Dec 2007 | EP |
1 379 186 | May 2009 | EP |
2 100 565 | Sep 2009 | EP |
1 523 278 | Nov 2009 | EP |
2 331 023 | Jun 2011 | EP |
1 845 874 | Oct 2012 | EP |
2 683 310 | Jan 2014 | EP |
2 688 498 | Jan 2014 | EP |
2 890 332 | Jul 2015 | EP |
200801551 | May 2008 | ES |
2 699 065 | Dec 1992 | FR |
2 728 778 | Dec 1994 | FR |
2 745 709 | Mar 1996 | FR |
2 800 601 | Nov 1999 | FR |
2 801 189 | Nov 1999 | FR |
2 808 182 | Apr 2000 | FR |
2157788 | Oct 1985 | GB |
2173565 | Oct 1986 | GB |
64-52439 | Feb 1989 | JP |
6-319742 | Nov 1994 | JP |
07-502419 | Mar 1995 | JP |
07-184922 | Jul 1995 | JP |
10-085232 | Apr 1998 | JP |
11-089854 | Apr 1999 | JP |
2004-194731 | Jul 2004 | JP |
2005-533627 | Nov 2005 | JP |
2011-511107 | May 2009 | JP |
4988203 | Aug 2012 | JP |
5164571 | Dec 2012 | JP |
WO 9109572 | Dec 1989 | WO |
WO 9304652 | Mar 1993 | WO |
WO 9628100 | Sep 1996 | WO |
WO 9952478 | Oct 1999 | WO |
WO 9962417 | Dec 1999 | WO |
WO 0067652 | May 2000 | WO |
WO 200076409 | Dec 2000 | WO |
WO 200112054 | Feb 2001 | WO |
WO 200154598 | Aug 2001 | WO |
WO 200180751 | Nov 2001 | WO |
WO 200243601 | Jun 2002 | WO |
WO 2002078555 | Oct 2002 | WO |
WO 2003021308 | Mar 2003 | WO |
WO 2003043488 | May 2003 | WO |
WO 2004008949 | Jan 2004 | WO |
WO 2004064603 | Aug 2004 | WO |
WO 2004078220 | Sep 2004 | WO |
WO 2004078221 | Sep 2004 | WO |
WO 2004098453 | Nov 2004 | WO |
WO 2005041818 | May 2005 | WO |
WO 2005112835 | Dec 2005 | WO |
WO 2006017507 | Feb 2006 | WO |
WO 2006063083 | Jun 2006 | WO |
WO 2006108067 | Oct 2006 | WO |
WO 2007048038 | Apr 2007 | WO |
WO 2007119212 | Oct 2007 | WO |
WO 2007124130 | Apr 2008 | WO |
WO 2008044057 | Apr 2008 | WO |
WO 2008070863 | Jun 2008 | WO |
WO 2008064842 | Nov 2008 | WO |
WO 2009047630 | Apr 2009 | WO |
WO 2006047363 | May 2009 | WO |
WO 2009152919 | Dec 2009 | WO |
WO 2009155577 | Dec 2009 | WO |
WO 2010011941 | Jan 2010 | WO |
WO 2010062971 | Jun 2010 | WO |
WO 2010136170 | Dec 2010 | WO |
WO 2010148112 | Dec 2010 | WO |
WO 2011046460 | Apr 2011 | WO |
WO 2011079910 | Jul 2011 | WO |
WO 2010135156 | Nov 2011 | WO |
WO 2011142761 | Nov 2011 | WO |
WO 2011150350 | Dec 2011 | WO |
WO 2012048008 | Apr 2012 | WO |
WO 2014036178 | Mar 2014 | WO |
Entry |
---|
Mar. 17, 2016 European Extended Search Report for Application No. 13832602.0, the European counterpart of the present application. |
Gray's Anatomy, Crown Publishers, Inc., 1977, pp. 33-54. |
U.S. Appl. No. 09/266,138, filed Mar. 10, 1999, Cachia. |
U.S. Appl. No. 11/417,904, filed May 3, 2006, von Hoffman et al. |
U.S. Appl. No. 11/417,904, filed May 3, 2006, Culbert. |
U.S. Appl. No. 14/470,820, filed Aug. 27, 2014, Lopez et al. |
U.S. Appl. No. 14/574,859, filed Dec. 18, 2014, Culbert et al. |
Alfen, et al., “Developments in the Area of Edoscopic Spine Surgery”. European Musculoskeletal Review 2006, pp. 23-24. ThessysTM, Transforminal Endoscopic Spine System. Medical Solutions, ioimax®. |
Brochure for PERPOS PLS System Surgical Technique by Interventional Spine. |
Brooks, M.D., et al. Efficacy of Supplemental Posterior Transfacet Pedicle Device Fixation in the Setting of One- or Two-Level Anterior Lumbar Interbody Fusion. |
Chin, Kingsley R., M.D. “Early Results of the Triage Medical Percutaneous Transfacet Pedicular BONE-LOK Compression Device for Lumbar Fusion”. |
Iprenburg, et al., “Transforaminal Endoscopic Surgery in Lumbar Disc Herniation in an Economic Crisis—The TESSYS Method”. US Musculoskeletal, 2008 pp. 47-49. |
James F. Zucherman, “A Multicenter, Prospective, Randomized Trial Evaluating the X STOP Interspinous Process Decompression System for the Treatment of Neurogenic Intermittent Claudication”, SPINE vol. 30, No. 12, pp. 1351-1358. |
Kambin, et al; Percutaneous Lateral Discectomy of the Lumbar Spine: A Preliminary Report; Clin. Orthop.; 1983; 174: 127-132. |
Kambin, et al; Percutaneous Posterolateral Discectomy. Anatomy and Mechanism; Clin. Orthop. Relat. Res.; Oct. 1987; 223: 145-154. |
King, M.D., Don, “Internal Fixation for Lumbosacral Fusion”, The Journal of Bone and Joint Surgery. J Bone Joint Surg Am. 1948; 30:560-578. |
Mahar, et al. Biomechanical Comparison of a Novel Percutaneous Transfacet Device and a Traditional Posterior System for Single Level Fusion. Journal of Spinal Disorders & Techniques, Dec. 2006, vol. 19 No. 8, pp. 591-594. |
Manal Siddiqui, “The Positional Magnetic Resonance Imaging Changes in the Lumbar Spine Following Insertion of a Novel Interspinous Process Distraction Device”, Spine vol. 30, No. 23, pp. 2677-2682. |
Medco Forum, “Percutaneous Lumbar Fixation Via PERPOS PLS System Interventional Spine”. Sep. 2008, vol. 15, No. 37. |
Medco Forum, “Percutaneous Lumbar Fixation via PERPOS System From Interventional Spine”. Oct. 2007, vol. 14, No. 49. |
Morgenstern R; Transforaminal Endoscopic Stenosis Surgery—A Comparative Study of Laser and Reamed Foraminoplasty.In: European Musculoskeletal Review, Issue 1,2009. |
Niosi, Christina A., “Biomechanical characterization of the three-dimentional kinematic behaviour of the Dynesys dynamic stabilization system: an in vitro study”, EUR SPINE J (2006) 15: pp. 913-922. |
Paul D. Fuchs, “The Use of an Interspinous Implant in Conjunction With a Graded Facetectomy Procedure”, SPINE vol. 30, No. 11, pp. 1266-1272. |
ProMapTM EMG Navigation Probe. Technical Brochure Spineology Inc., dated May 2009. |
Vikram Talwar, “Insertion loads of the X STOP interspinous process distraction system designed to treat neurogenic intermittent claudication”, EUR SPINE J (2006) 15: pp. 908-912. |
Number | Date | Country | |
---|---|---|---|
20150223948 A1 | Aug 2015 | US |
Number | Date | Country | |
---|---|---|---|
61694947 | Aug 2012 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13794067 | Mar 2013 | US |
Child | 14424412 | US |